EurekaMag Full Text Articles Chapter 45,345

Whicher, J.T. 1998: BCR/IFCC reference material for plasma proteins (CRM 470). Community Bureau of Reference. International Federation of Clinical Chemistry. Clinical Biochemistry 31(6): 459-465

Sorscher, S.; Levonian, P. 1997: BCRA 1 testing guidelines for high-risk patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(4): 1711

Norman 1991: BCS gap equations in the quantum limit. Physical Review Letters 66(6): 842

Ramakumar; Kumar; Jain; Chancey 1993: BCS pairing in a correlated narrow-band metal. Physical Review. B Condensed Matter 48(9): 6509-6512

Jankó; Smith; Ambegaokar 1994: BCS superconductivity with fixed number parity. Physical Review. B Condensed Matter 50(2): 1152-1161

Lal; Joshi 1992: BCS theory of superconductivity as modified by Coulomb interaction in cuprates. Physical Review. B Condensed Matter 45(1): 361-369

Weisz 1993: BCS theory of two-dimensional Landau-level superconductivity. Physical Review. B Condensed Matter 48(9): 6330-6333

Quick; Esebbag; de Llano M 1993: BCS theory tested in an exactly solvable fermion fluid. Physical Review. B Condensed Matter 47(17): 11512-11514

Appel; Fay 1990: BCS versus Josephson pair hopping between the CuO2 layers in high-Tc superconductors. Physical Review. B Condensed Matter 41(1): 873-876

Ohashi, Y.; Griffin, A. 2002: BCS-BEC crossover in a gas of Fermi atoms with a Feshbach resonance. Physical Review Letters 89(13): 130402

Casas; Getino; de Llano M; Puente; Quick; Rubio; van der Walt DM 1994: BCS-Bose model of exotic superconductors: Generalized coherence length. Physical Review. B Condensed Matter 50(21): 15945-15952

Hesper; Tjeng; Heeres; Sawatzky 2000: BCS-like density of states in superconducting A3C60 surfaces. Physical Review Letters 85(9): 1970-1973

Phillips, P.K.; Voak, D.; Whitton, C.M.; Downie, D.M.; Bebbington, C.; Campbell, J. 1993: BCSH-NIBSC anti-D reference reagent for antiglobulin tests: the in-house assessment of red cell washing centrifuges and of operator variability in the detection of weak, macroscopic agglutination. British Committee for Standards in Haematology. National Institute for Biological Standards and Control. Transfusion Medicine 3(2): 143-148

Skundrić, A.; Matić, S.; Odavić, M.; Lazić, Z. 1997: BCT Implant System. Vojnosanitetski Pregled 54(4 Suppl): 77-79

Anonymous 1999: BCTP sounds its battle cry. Environmental Health Perspectives 107(2): A64-A65

Babu, Y.S.; Chand, P.; Bantia, S.; Kotian, P.; Dehghani, A.; El-Kattan, Y.; Lin, T.H.; Hutchison, T.L.; Elliott, A.J.; Parker, C.D.; Ananth, S.L.; Horn, L.L.; Laver, G.W.; Montgomery, J.A. 2000: BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. Journal of Medicinal Chemistry 43(19): 3482-3486

Roberts, J. 1999: BDA accreditation causes concern. British dental journal 187(8): 406

Ansorg, J. 2000: BDC (Professional Society of German Surgeons) online. New internet presence of the professional society. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 71(9): Suppl. 244-5

Dzionek, A.; Fuchs, A.; Schmidt, P.; Cremer, S.; Zysk, M.; Miltenyi, S.; Buck, D.W.; Schmitz, J. 2000: BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology 165(11): 6037-6046

Schmidt, K. 2001: BDI plans "general and family medicine". "Light" internist as better family physician. MMW Fortschritte der Medizin 143(46): 54

Anderssohn, M.D. 1993: BDJ re-design. British Dental Journal 174(7): 232-233

Fukumitsu, H.; Ohashi, A.; Nitta, A.; Nomoto, H.; Furukawa, S. 1997: BDNF and NT-3 modulate expression and threonine phosphorylation of microtubule-associated protein 2 analogues, and alter their distribution in the developing rat cerebral cortex. Neuroscience Letters 238(3): 107-110

Kobayashi, N.R.; Fan, D.P.; Giehl, K.M.; Bedard, A.M.; Wiegand, S.J.; Tetzlaff, W. 1997: BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(24): 9583-9595

Reibel, S.; Depaulis, A.; Larmet, Y. 2001: BDNF and epilepsy--the bad could turn out to be good. Trends in Neurosciences 24(6): 318-319

Bartrup, J.T.; Moorman, J.M.; Newberry, N.R. 1997: BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures. Neuroreport 8(17): 3791-3794

Cohen-Cory, S.; Fraser, S.E. 1994: BDNF in the development of the visual system of Xenopus. Neuron 12(4): 747-761

Klöcker, N.; Jung, M.; Stuermer, C.A.; Bähr, M. 2001: BDNF increases the number of axotomized rat retinal ganglion cells expressing GAP-43, L1, and TAG-1 mRNA--a supportive role for nitric oxide?. Neurobiology of Disease 8(1): 103-113

Rivera, C.; Li, H.; Thomas-Crusells, J.; Lahtinen, H.; Viitanen, T.; Nanobashvili, A.; Kokaia, Z.; Airaksinen, M.S.; Voipio, J.; Kaila, K.; Saarma, M. 2002: BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. Journal of Cell Biology 159(5): 747-752

Frost, D.O. 2001: BDNF/trkB signaling in the developmental sculpting of visual connections. Progress in Brain Research 134: 35-49

Anonymous 1999: BDR erreicht ruckwirkende anderungen zu Angio/Interventionen. Der Radiologe 39(8): 138

Jøsendal, O.; Aarø, L.Edvard. 2002: BE smokeFREE--evaluation of an intervention program for smoke-free schools. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(4): 403-407

Lund, K.Erik.; Lühr, E.; Jøsendal, O. 2002: BE smokeFREE--from trials to national implementation. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(4): 408-414

Diehl, V.; Franklin, J.; Hasenclever, D.; Tesch, H.; Pfreundschuh, M.; Lathan, B.; Paulus, U.; Sieber, M.; Rüffer, J.U.; Sextro, M.; Engert, A.; Wolf, J.; Hermann, R.; Holmer, L.; Stappert-Jahn, U.; Winnerlein-Trump, E.; Wulf, G.; Krause, S.; Glunz, A.; von Kalle, K.; Bischoff, H.; Haedicke, C.; Dühmke, E.; Georgii, A.; Loeffler, M. 1998: BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(Suppl 5): S67-S71

Diehl, V.; Sieber, M.; Rüffer, U.; Lathan, B.; Hasenclever, D.; Pfreundschuh, M.; Loeffler, M.; Lieberz, D.; Koch, P.; Adler, M.; Tesch, H. 1997: BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. the German Hodgkin's Lymphoma Study Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(2): 143-148

Cortelazzo, S.; Rossi, A.; Viero, P.; Bellavita, P.; Marchioli, R.; Marfisi, R.M.; Rambaldi, A.; Barbui, T. 1997: BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma. British Journal of Haematology 99(2): 379-385

Zeelenberg, C.; Kolitsi, Z.; Kapsalis, V.; Van Nimwegen, C.; Pallikarakis, N. 1997: BEAM@Net: telematic services for clinical engineers and medical physicists. Studies in Health Technology and Informatics 43 Pt A: 109-113

Worley, K.C.; Culpepper, P.; Wiese, B.A.; Smith, R.F. 1998: BEAUTY-X: enhanced BLAST searches for DNA queries. Bioinformatics 14(10): 890-891

Worley, K.C.; Wiese, B.A.; Smith, R.F. 1995: BEAUTY: an enhanced BLAST-based search tool that integrates multiple biological information resources into sequence similarity search results. Genome Research 5(2): 173-184

Arnold, P.; Moore, G. 2001: BEC transition temperature of a dilute homogeneous imperfect Bose gas. Physical Review Letters 87(12): 120401

Yoshino, G.; Hirano, T.; Kazumi, T. 2001: BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 433-435

Sinclair, J.A.; Oates, J.P.; Dale, R.G. 1999: BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments. International Journal of Radiation Oncology Biology Physics 44(2): 381-389

Gary, S.C.; Hockfield, S. 2000: BEHAB/brevican: an extracellular matrix component associated with invasive glioma. Clinical Neurosurgery 47: 72-82

Anonymous 1999: BELLE Newsletter. Human and Experimental Toxicology 18(7): 418

Martínez, G.; Tsuno, K. 2002: BEM simulation of Wien filters. Ultramicroscopy 93(3-4): 253-261

Anonymous 1993: BEMFAM delivers AIDS alert. Forum 9(1): 12

Lowy, M.E.; Matyas, M.L. 2002: BEN portal--your doorway to a broader range of teaching material. Advances in Physiology Education 26(1-4): 67-68

Aoyagi, S.; Sugiyama, M.; Fukuda, H. 1998: BEN1 and ZEN1 cDNAs encoding S1-type DNases that are associated with programmed cell death in plants. Febs Letters 429(2): 134-138

Kaina, B.; Ochs, K.; Grösch, S.; Fritz, G.; Lips, J.; Tomicic, M.; Dunkern, T.; Christmann, M. 2001: BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Progress in Nucleic Acid Research and Molecular Biology 68: 41-54

Cryz, S.J. 1999: BERNA: a century of immunobiological innovation. Vaccine 17(Suppl 2): S1-S5

Hagemo, P.S. 1994: BERTE--a database for children with congenital heart defects. Studies in Health Technology and Informatics 14: 98-101

Kumar, S.; Jayaraman, K.; Panchanathan, S.; Gurunathan, R.; Marti-Subirana, A.; Newfeld, S.J. 2002: BEST: a novel computational approach for comparing gene expression patterns from early stages of Drosophila melanogaster development. Genetics 162(4): 2037-2047

Clausen; Fabricius 2000: BET Measurements: Outgassing of Minerals. Journal of Colloid and Interface Science 227(1): 7-15

Dib, K. 2000: BETA 2 integrin signaling in leukocytes. Frontiers in Bioscience: a Journal and Virtual Library 5: D438-D451

Jain, A.K. 2000: BETARU: an indigenously designed cordless stethoscope. Indian Pediatrics 37(5): 566-567

Bradley, P.; Cowen, L.; Menke, M.; King, J.; Berger, B. 2001: BETAWRAP: successful prediction of parallel beta -helices from primary sequence reveals an association with many microbial pathogens. Proceedings of the National Academy of Sciences of the United States of America 98(26): 14819-14824

Jonsson, S.Y.; Löfström, C.M.; Bäckvall, J.E. 2000: BF(3)-Induced rearrangement of aziridino cyclopropanes derived from 2-phenylsulfonyl 1,3-dienes. Application to the total synthesis of (+/-)-ferruginine. Journal of Organic Chemistry 65(25): 8454-8457

Hardouin, C.; Taran, F.; Doris, E. 2001: BF3*OET2-mediated rearrangement of cyclopropyl carbinols: a concise route to polycyclic cyclobutanes. Journal of Organic Chemistry 66(12): 4450-4452

Havlícek, V.; Jegorov, A.; Sedmera, P.; Ryska, M. 1995: BF3-catalysed methanolysis combined with fast atom bombardment tandem mass spectrometry as a new tool for the preparation and analysis of linear secocyclosporins. Rapid Communications in Mass Spectrometry: Rcm Spec No: S158-S164

Tamura, O.; Mitsuya, T.; Ishibashi, H. 2002: BF3.OEt2-mediated cycloaddition of O-tert-butyldimethylsilyloximes having olefin moieties: intramolecular cycloaddition of N-borano-nitrones. Chemical Communications 10: 1128-1129

Amorim; Barcelos-Neto 1996: BFF quantization of chiral-boson theories. Physical Review. D Particles and Fields 53(12): 7129-7137

Kumar, S. 1997: BFHI: a step towards protecting fundamental rights of newborns. Indian Pediatrics 34(9): 841-843

Aird, I.; Barratt, C.; Murdoch, A. 2000: BFS Recommendations for Good Practice on the Screening of Egg and Embryo Donors. Human Fertility 3(3): 162-165

Nugent, D.; Hamilton, M.; Murdoch, A. 2000: BFS Recommendations for Good Practice on the Storage of Ovarian and Prepubertal Testicular Tissue. Human Fertility 3(1): 5-8

Ye, X.; Zhu, J.; Wang, H. 2017: Advances in quorum-sensing LuxR solos in bacteria. Wei Sheng Wu Xue Bao 57(3): 341-349

Fujiwara; Igarashi; Kuriki; Tabei 1996: BFV-BRST quantization of two-dimensional supergravity. Physical Review. D Particles and Fields 53(2): 852-869

Shimada, S.; Shiomori, K.; Honmyo, U.; Maeno, M.; Yagi, Y.; Ogawa, M. 2002: BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 5(3): 130-136

Barbosa, A.J.A.; Castro, L.P. 2002: BGP expression in gastric epithelium and early gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 5(3): 123-124

Huang, D.C.; Strasser, A. 2000: BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103(6): 839-842

Sciuto, A.M.; Moran, T.S. 1999: BHA diet enhances the survival of mice exposed to phosgene: the effect of BHA on glutathione levels in the lung. Inhalation Toxicology 11(9): 855-871

Deng, W.; Lin, S.H. 2018: Advances in radiotherapy for esophageal cancer. Annals of Translational Medicine 6(4): 79

Anonymous 1982: BHP to enforce staffing level requirements; half of HSAs may fold. Health Planning and Manpower Report 11(3): 1-2

Salter, H.; Zammit, L.; Horsburgh, T.; Drysdale, L. 2000: BHP--a Broken Hill perspective. Health Information Management: Journal of the Health Information Management Association of Australia 29(4): 189-191

Huang, H.; Pan, X.; Zhou, J. 1999: BHRF1 antisense oligonucleotide inhibits anti-apoptosis of nasopharyngeal carcinoma cells. International Journal of Molecular Medicine 4(6): 649-653

Friedlander, R. 1993: BHSM comes to the Flathead Indian Reservation. Asha 35(5): 28-30

Metzner, M.; Hofmann, W.; Lessmann, H.W. 1993: BHV-1 intradermal test in cattle. Tierarztliche Praxis 21(3): 189-191

Rodilla, J.M.; De Mendonça, D.I.; Ismael, M.I.; Figueiredo, J.A.; Silva, M.L.; Lopes, E. 2001: BI- and tricyclic diterpenoids from Halimium viscosum. Natural Product Letters 15(6): 401-409

Sitges-Serra, A.; Lobo, D.N. 2001: BIA without measuring height: a one-wheeled bicycle. Clinical Nutrition 20(1): 9

Nelson, R.W.; Jarvik, J.W.; Taillon, B.E.; Tubbs, K.A. 1999: BIA/MS of epitope-tagged peptides directly from E. coli lysate: multiplex detection and protein identification at low-femtomole to subfemtomole levels. Analytical Chemistry 71(14): 2858-2865

Vély, F.; Trautmann, A.; Vivier, E. 2000: BIAcore analysis to test phosphopeptide-SH2 domain interactions. Methods in Molecular Biology 121: 313-321

Dunea 1999: BIBA but LGFTD. Bmj 319(7222): 1445a

Zelnio, R.N.; Gagnon, J.P.; Pashion, V.L. 1977: BIBLIO: a reprint file management algorithm. American Journal of Pharmaceutical Education 41(1): 44-47

Zhang, P.; Zheng, J.; Hexum, T.D. 1998: BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion. European Journal of Pharmacology 362(2-3): 121-125

Mungall, D. 2002: BIBR-1048 Boehringer Ingelheim. Current Opinion in Investigational Drugs 3(6): 905-907

Buckley, A.W. 1985: BIBS program helps families at risk of child abuse. Health Progress 66(9): 16

Catán, F.; Uribe, M.; Carvajal, C.; Cavalleri, S.; Pizarro, F.; Uribe, J.P.; Uribe-Echevarría, S.; López, C.; Venegas, L. 2000: BICAP tumor probe in the palliative treatment of malignant esophageal stenosis. Revista Medica de Chile 128(5): 513-518

Censor, Y.; Gordon, D.; Gordon, R. 2001: BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Transactions on Medical Imaging 20(10): 1050-1060

Plesnila, N.; Zinkel, S.; Le, D.A.; Amin-Hanjani, S.; Wu, Y.; Qiu, J.; Chiarugi, A.; Thomas, S.S.; Kohane, D.S.; Korsmeyer, S.J.; Moskowitz, M.A. 2001: BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America 98(26): 15318-15323

Hamon, A.; Le Corronc, H.; Hue, B.; Rauh, J.J.; Sattelle, D.B. 1998: BIDN, a bicyclic dinitrile convulsant, selectively blocks GABA-gated Cl- channels. Brain Research 780(1): 20-26

Yoshihara, Y.; Kawasaki, M.; Tani, A.; Tamada, A.; Nagata, S.; Kagamiyama, H.; Mori, K. 1994: BIG-1: a new TAG-1/F3-related member of the immunoglobulin superfamily with neurite outgrowth-promoting activity. Neuron 13(2): 415-426

Pacheco-Rodriguez, G.; Moss, J.; Vaughan, M. 2002: BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors. Methods in Enzymology 345: 397-404

Kocak-Altintas, A.G.; Kocak-Midillioglu, I.; Akarsu, A.N.; Duman, S. 2001: BIGH3 gene analysis in the differential diagnosis of corneal dystrophies. Cornea 20(1): 64-68

Kim, H.S.; Yoon, S.K.; Cho, B.J.; Kim, E.K.; Joo, C.K. 2001: BIGH3 gene mutations and rapid detection in Korean patients with corneal dystrophy. Cornea 20(8): 844-849

Meythaler, J. 2002: BIII-890-CL. Boehringer Ingelheim. Current Opinion in Investigational Drugs 3(12): 1733-1735

Borsini, F.; Cesana, R.; Kelly, J.; Leonard, B.E.; McNamara, M.; Richards, J.; Seiden, L. 1997: BIMT 17: a putative antidepressant with a fast onset of action?. Psychopharmacology 134(4): 378-386

Bader, G.D.; Donaldson, I.; Wolting, C.; Ouellette, B.F.; Pawson, T.; Hogue, C.W. 2001: BIND--The Biomolecular Interaction Network Database. Nucleic Acids Research 29(1): 242-245

Bader, G.D.; Hogue, C.W. 2000: BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bioinformatics 16(5): 465-477

Reetz, M.T.; Moulin, D.; Gosberg, A. 2001: BINOL-based diphosphonites as ligands in the asymmetric Rh-catalyzed conjugate addition of arylboronic acids. Organic Letters 3(25): 4083-4085

Moore, D.; Pu, L. 2002: BINOL-catalyzed highly enantioselective terminal alkyne additions to aromatic aldehydes. Organic Letters 4(11): 1855-1857

DiMauro, E.F.; Kozlowski, M.C. 2001: BINOL-salen metal catalysts incorporating a bifunctional design. Organic Letters 3(11): 1641-1644

Casas, Jús.; Nájera, C.; Sansano, Jé.M.; Saá, Jé.M. 2002: BINOLAM, a recoverable chiral ligand for bifunctional enantioselective catalysis: the asymmetric synthesis of cyanohydrins. Organic Letters 4(15): 2589-2592

Schlegel, A.K.; Donath, K. 1998: BIO-OSS--a resorbable bone substitute?. Journal of Long-Term Effects of Medical Implants 8(3-4): 201-209

Rone, R. 2000: BIO2000. Biotechnology Industry Organization Conference. Boston, Massachusetts, USA. March 26-30, 2000. Journal of Molecular Graphics and Modelling 18(2): 180-181

Van Camp, A.J. 1992: BIOETHICSLINE and other sources of ethics information. Database 15(4): 102-105

Darragh, M. 1998: BIOETHICSLINE on the World Wide Web. Kennedy Institute of Ethics Journal 8(4): 467-468

Dorsch, J.L. 1997: BIOETHICSLINE use by medical students: curriculum-integrated instruction and collection development implications. Bulletin of the Medical Library Association 85(2): 147-153

Kahn, T.J.; Orr, C. 1984: BIOETHICSLINE: an overview for searchers. Medical Reference Services Quarterly 3(3): 1-21

Mann, J.; Ramakrishna, R.; Magge, R.; Wernicke, A.G. 2017: Advances in Radiotherapy for Glioblastoma. Frontiers in Neurology 8: 748

Anonymous 2002: BIOLASE and UCLA successfully complete first Waterlase sinus surgery in the United States. Dentistry Today 21(8): 27

Anonymous 2002: BIOLASE receives first-ever FDA clearance for complete laser root canal therapy. Dentistry Today 21(3): 30

Ni, J. 2000: BIOME 6000 Project: latest advances of reconstructing palaeobiome. Ying Yong Sheng Tai Xue Bao 11(3): 465-471

Lucio, P.; Gaipa, G.; van Lochem, E.G.; van Wering, E.R.; Porwit-MacDonald, A.; Faria, T.; Bjorklund, E.; Biondi, A.; van den Beemd, M.W.; Baars, E.; Vidriales, B.; Parreira, A.; van Dongen, J.J.; San Miguel, J.F.; Orfao, A. 2001: BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. Leukemia 15(8): 1185-1192

Scheepers, P.T.J.; Coggon, D.; Knudsen, L.E.; Anzion, R.; Autrup, H.; Bogovski, S.; Bos, R.P.; Dahmann, D.; Farmer, P.; Martin, E.A.; Micka, V.; Muzyka, V.; Neumann, H.G.; Poole, J.; Schmidt-Ott, A.; Seiler, F.; Volf, J.; Zwirner-Baier, I. 2002: BIOMarkers for occupational diesel exhaust exposure monitoring (BIOMODEM)--a study in underground mining. Toxicology Letters 134(1-3): 305-317

Sanchez-Nieto, B.; Nahum, A.E. 2000: BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans. Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists 25(2): 71-76

Bartsev, S.I.; Mezhevikin, V.V.; Okhonin, V.A. 1996: BIOS-4 as an embodiment of CELSS development conception. Advances in Space Research: the Official Journal of the Committee on Space Research 18(1-2): 201-204

O'Sullivan, C.; Alcock, S.J. 1999: BIOSET: Biosensors for Environmental Technology EU Workshop 'Biosensors for Environmental Monitoring: Technology Evaluation'. Held in Kinsale, Ireland, 12-15 May 1998. Biosensors and Bioelectronics 14(6): 541-544

Prasek, M.A. 1998: BIOSIS previews: the power of codes. Medical Reference Services Quarterly 17(2): 43-49

Kirmse, M.; Bremer, F. 2000: BIPAP--a forward-looking ventilation mode? Contra. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 35(11): 714-716

Silver, M.R. 1998: BIPAP: useful new modality or confusing acronym?. Critical Care Medicine 26(9): 1473-1474

Harboe, S.; Söreide, E. 2000: BIPAP: useful new modality?. Critical Care Medicine 28(5): 1691-1692

Imison, A. 2000: BIPP aspiration. Anaesthesia and Intensive Care 28(3): 335-336

Lillicrap, S.C. 1993: BIR presidential address: exploring the niches. British Journal of Radiology 66(784): 283-291

Hately, W. 1993: BIR presidential address: the challenge of change. British Journal of Radiology 66(792): 1087-1094

Mondello, E.; Panasiti, R.; Siliotti, R.; Floridia, D.; David, A.; Trimarchi, G. 2002: BIS and Ramsay score in critically ill patient: what future?. Minerva Anestesiologica 68(1-2): 37-43

Yamaguchi, F.; Oi, Y.; Aoki, W.; Nakamura, R.; Igarashi, A.; Kubota, M.; Sawada, K.; Shimura, T.; Takahashi, H.; Kobayashi, S.; Teramoto, A. 2002: BIS monitoring is useful for reliable intraoperative cortical mapping during brain tumor operations. No Shinkei Geka. Neurological Surgery 30(11): 1181-1188

Mérat, S.; Lévecque, J.P.; Le Gulluche, Y.; Diraison, Y.; Brinquin, L.; Hoffmann, J.J. 2001: BIS monitoring may allow the detection of severe cerebral ischemia. Canadian Journal of Anaesthesia 48(11): 1066-1069

Spackman, T.N.; Abel, M.D. 2002: BIS monitoring: there's more to it than awareness. Anesthesiology 96(1): 255-256

Parisi, A.; Bartolazzi, A.; Bonino, C.; Camagna, M.; DeMonte, L.B.; Lombardi, A.; Natali, P.G.; Paganelli, G.; Tarditi, L.; Vassarotto, C. 1993: BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy. Year in Immunology 7: 96-105

Ohnishi, H.; Kubota, M.; Sano, S. 1997: BIT (Bit) maps to mouse chromosome 2. Genomics 40(3): 504-506

Gibbons, R.W.; Palmer, B.J. 1994: BJ in 1906: predictions and personal reflections. Chiropractic History: the Archives and Journal of the Association for the History of Chiropractic 14(1): 10-12

Stare, J.; Harrell, F.E.; Heinzl, H. 2001: BJ: an S-Plus program to fit linear regression models to censored data using the Buckley-James method. Computer Methods and Programs in Biomedicine 64(1): 45-52

Hall, G.M. 1998: BJA citation classics 1945-1992. British Journal of Anaesthesia 80(1): 4-6

Smith, G. 2001: BJA concise - a step too far. British Journal of Anaesthesia 87(2): 185

Scott, L. 1995: BJC Health System expands its reach. Modern Healthcare 25(10): 48

Matheny, M. 1996: BJC Health System: the perils of a proactive strategy. Health System Leader 3(2): 12-19

Moore, J.D. 1998: BJC chief to step down. Brown will resign to focus on AHA chairman post. Modern healthcare 28(32): 2-3

Scott, L. 1994: BJC to reorganize services. Modern Healthcare 24(47): 34

Tate, S.; Cook, H. 1996: Postoperative nausea and vomiting. 1: Physiology and aetiology. British Journal of Nursing 5(16): 962; 964 966 Passim

Tracy, C. 1995: Orthodontics in Germany. Recent changes to the remunerative system. British Journal of Orthodontics 22(4): 388-390

Webb 2000: BJS and the blitz. British Journal of Surgery 87(12): 1731

Murie; Farndon 2000: BJS in the new millennium. British Journal of Surgery 87(1): 1-2

Nickel 2000: BJU international volume 85, number 2, january 2000 european urology update series 2000:1 prostatitis: lessons from the 20th century. Bju International 85(2): 1-4

Ransom, C.B.; Liu, X.; Sontheimer, H. 2002: BK channels in human glioma cells have enhanced calcium sensitivity. Glia 38(4): 281-291

Tanaka, Y.; Horinouchi, T.; Tanaka, H.; Shigenobu, K.; Koike, K. 2002: BK channels play an important role as a negative feedback mechanism in the regulation of spontaneous rhythmic contraction of urinary bladder smooth muscles. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 106p-108p

Garavelli, P.L.; Boldorini, R. 2002: BK virus encephalitis in an HIV-seropositive patient. Preliminary data. Recenti Progressi in Medicina 93(4): 247

Lin, P.L.; Vats, A.N.; Green, M. 2001: BK virus infection in renal transplant recipients. Pediatric Transplantation 5(6): 398-405

Fishman, J.A. 2002: BK virus nephropathy--polyomavirus adding insult to injury. New England Journal of Medicine 347(7): 527-530

Stoner, G.L.; Alappan, R.; Jobes, D.V.; Ryschkewitsch, C.F.; Landry, M.L. 2002: BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 39(5): 1102-1112

Bachman, D.M. 1999: BK virus retinitis. Ophthalmology 106(12): 2232

Iwamoto, S.; Azuma, E.; Hori, H.; Hirayama, M.; Kobayashi, M.; Komada, Y.; Nishimori, H.; Miyahara, M. 2002: BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatric Hematology and Oncology 19(4): 255-261

Petrogiannis-Haliotis, T.; Sakoulas, G.; Kirby, J.; Koralnik, I.J.; Dvorak, A.M.; Monahan-Earley, R.; DE Girolami, P.C.; DE Girolami, U.; Upton, M.; Major, E.O.; Pfister, L.A.; Joseph, J.T. 2001: BK-related polyomavirus vasculopathy in a renal-transplant recipient. New England Journal of Medicine 345(17): 1250-1255

Benvenisty, N.; Ornitz, D.M. 1995: BK1: an FGF-responsive central nervous system-derived cell line. Growth Factors 12(1): 49-55

Suyono, H. 1989: BKKBN and the expanding role of private sector FP services and commercial contraceptive sales in Indonesia. Integration 20: 19-23

Gaëta, B. 2000: BLAST ... what next?. Biotechniques 28(5): 874-876

Boone, M.; Upton, C. 2000: BLAST Search Updater: a notification system for new database matches. Bioinformatics 16(11): 1054-1055

Mullan, L.J.; Williams, G.W. 2002: BLAST and go?. Briefings in Bioinformatics 3(2): 200-202

Gaëta, B.A. 2000: BLAST on the Web. Biotechniques 28(3): 436 438 440

Kent, W.J. 2002: BLAT--the BLAST-like alignment tool. Genome Research 12(4): 656-664

Soussi, T. 2001: BLM (RCQL2) or Bloom Syndrome. Bulletin du Cancer 88(2): 129-130

Ishiai, M.; Kurosaki, M.; Pappu, R.; Okawa, K.; Ronko, I.; Fu, C.; Shibata, M.; Iwamatsu, A.; Chan, A.C.; Kurosaki, T. 1999: BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity 10(1): 117-125

Ciafaloni, M.; Ciafaloni, P.; Comelli, D. 2001: BLOCH-Nordsieck violation in spontaneously broken Abelian theories. Physical Review Letters 87(21): 211802

Spoor, J.E. 1983: BLS (basic life support) is not enough. Emergency Medical Services 12(1): 42; 44-45

Root, N.; Sebastian, D. 1981: BLS develops measure of job risk by occupation. Monthly Labor Review 104(10): 26-30

Skoog, A.I. 1984: BLSS: a contribution to future life support. Advances in Space Research: the Official Journal of the Committee on Space Research 4(12): 251-262

Annest, J.L.; Mahaffey, K.R.; Cox, D.H.; Roberts, J. 1982: BLood lead levels for persons 6 months-74 years of age: United States, 1976-80. Advance data 1982(79): 1-23

Zhou, T.; Zhang, J.; Carter, R.; Kimberly, R. 2003: BLyS and B cell autoimmunity. Current Directions in Autoimmunity 6: 21-37

Dogné, J.M.; Neven, P.; Damas, J.; Fontaine, J.; Rolin, S.; De Leval, X.; Delarge, J.; Masereel, B. 1999: BM 144: an original thromboxane A2 receptor antagonist derived from torasemide. Journal de Pharmacie de Belgique 54(2): 57-58

Krause, D.S. 2002: BM-derived stem cells for the treatment of nonhematopoietic diseases. CytoTherapy 4(6): 503-506

Valle, P.C.; Dybdahl, J.H. 1998: BM-test Colon Albumin for determination of fecal occult blood. on what reasons was the refusion by the Risktrygdeverket based?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(16): 2529-2531

Beecham, L. 2000: BMA accused of contempt of court. Bmj 320(7232): 401

Ashraf, H. 1999: BMA address the issue of withholding and withdrawing treatment. Lancet 353(9171): 2220

Bowen, E. 1987: Fateful decisions on treating AIDS. Time 129(5): 62

Dean, M. 2000: BMA and NICE under attack over family doctor's targets. British Medical Association. National Institute for Clinical Excellence. Lancet 356(9245): 1909

Colabrese, C.A. 1982: In re Storar: the right to die and incompetent patients. University of Pittsburgh Law Review. University of Pittsburgh. School of Law 43(4): 1087-1107

Moore, R.A.; McQuay, H.J.; Oldman, A.D.; Smith, L.E. 2000: BMA approves acupuncture. BMA report is wrong. Bmj 321(7270): 1220-1221

Kovacs, F.M.; Gil del Real, M.T. 2000: BMA approves acupuncture. Is approval of acupuncture for back pain really evidence based?. Bmj 321(7270): 1221

Fordham, S. 1997: BMA asks for 53% pay increase. General practitioners want parity with hospital consultants. Bmj 314(7073): 77

Joseph, A.E. 1997: BMA asks for 53% pay increase. Morality of such claims is doubtful in light of growing disparity in society. Bmj 314(7073): 77

Ferriman 1999: BMA backs junior doctors' fight against government. Bmj 319(7202): 74

Anonymous 2002: BMA calls for ban on smoking in public places. practising midwife 5(11): 8

Woodman, R. 1999: BMA calls for extra safeguards for life and death decisions. Bmj 318(7200): 1717

Price 1999: Desperately seeking solutions: rationing health care. Bmj 318(7175): 64

Burke 1999: BMA calls for independent commissioner on child health. Bmj 319(7202): 75

Anonymous 1999: BMA calls for renewed action on debt relief. Bmj 318(7186): 815

Anonymous 1998: BMA calls for risk management approach to stress. Bmj 316(7142): 1465

Beecham, L. 1998: BMA calls for smoking to be banned in public places. Bmj 316(7137): 1037

Black 1999: Small wars: the cultural politics of childhood. Bmj 319(7202): 130

Xu, Z.-h.; Huang, W.; Lin, D.; Ge, X.-s.; Lin, X.-l.; Feng, S.-y.; Li, Y.-z.; Chen, R. 2016: Advances in Raman Spectroscopy for Nasopharyngeal Carcinoma Tissue. Guang Pu Xue Yu Guang Pu Fen Xi 36(8): 2518-2521

Anonymous 1998: BMA council agrees structure for devolution. Bmj 316(7144): 1615

Holden 2000: Diagnosing cancer in primary care. Bmj 320(7231): 387

Warden, J. 1995: BMA criticises guidance on long term care. Bmj 310(6979): 550-551

Morant, H. 2000: BMA demands more responsible media attitude on body image. Bmj 320(7248): 1495

Jessiman, I.M. 1996: BMA division disagrees with association's stance over advance directives. Bmj 312(7034): 850-851

Gall-Clayton, N. 1978: Beal, Maher and Poelker: the end of an era?. Journal of Family Law 17(1): 49-92

Anonymous 1999: BMA ends link with healthcall. Bmj 318(7180): 403

Anonymous 1999: BMA establishes racial equality committee. Bmj 319(7216): 1076

Richmond, C. 2000: BMA gives thumbs down to regulatory body. Cmaj: Canadian Medical Association Journal 163(4): 432

Koryagin, A. 1988: World psychiatry: readmitting the Soviet Union. Lancet 2(8605): 268-269

Dyer, C. 2002: BMA has to pay 815000 pounds sterling in damages for indirect racial discrimination. Bmj 324(7353): 1541

Anonymous 1999: BMA hopes for at least 10% pay rise. Bmj 318(7177): 199

Craft, N. 1996: BMA issues new guidance on surrogacy. Bmj 312(7028): 397-398

Hollowood; Rogers 1999: Forensic sciences in clinical medicine: a case study approach. Bmj 318(7193): 1294

Ferriman, A. 2000: BMA launches review on UK healthcare spending. Bmj 320(7242): 1096

Dobson, R. 2001: BMA may seek legal challenge over curbs on private practice. Bmj 322(7285): 507

Redgrave, P.; Waller, J. 1998: BMA must voice its opposition to Cuban embargo. Bmj 316(7139): 1248

Moore, W. 2002: BMA negotiator calls for more male medical students. Bmj 324(7340): 754

Anonymous 1998: BMA notice. Bmj 317(7158): G

Woodman, R. 1999: BMA opens door on human reproductive cloning. Bmj 319(7216): 1023

Beecham, L. 1997: BMA opposes legalisation of euthanasia. Bmj 315(7100): 80

Grabham, T. 2002: BMA president clarifies his message. Bmj 325(7357): 221

Smith, R. 2001: BMA president warns doctors not to take public esteem for granted. Bmj 323(7304): 70

Scott, H. 2002: BMA proposes radical changes to the nursing role. British Journal of Nursing 11(5): 296

Fricker, J. 1999: BMA proposes strategy to reformulate waiting lists. Bmj 318(7176): 78

Beecham, L. 2001: BMA remains concerned about GMC structure. Bmj 323(7304): 69

Anonymous 2000: BMA responds to proposals on the GMC. Bmj 320(7244): 1280

Beecham, L. 1994: BMA says fetal tissue should not be used for treatment. Bmj 308(6940): 1375

Beecham, L. 1993: BMA says no to mandatory HIV testing. Bmj 306(6892): 1618

Eaton 2002: BMA says world is ill prepared for bioterrorism. Bmj 325(7368): 794

Beecham, L. 2000: BMA secretary to be Scottish CMO. Bmj 321(7262): 654

Yates, J. 1996: BMA should look at inequalities in the NHS. Bmj 312(7035): 913

Gillett 1999: The last resort: psychosurgery and the limits of medicine. Bmj 318(7176): 132

Gulland, A. 2002: BMA steps up call for ban on smoking in public places. Bmj 325(7372): 1058

Beecham, L. 2001: BMA supports GPs' quest for new contract. Bmj 323(7304): 70

Flicker 2000: Practising evidence based geriatrics. Bmj 321(7255): 246

Beecham, L. 1998: BMA to consult on withdrawing treatment. Bmj 317(7152): 165

Mayor, S. 1997: BMA wants licensing of cannabis to be changed. Bmj 315(7119): 1329

Baird, A.G.; Donnelly, C.M.; Miscampell, N.T.; Wemyss, H.D. 2000: Centralisation of cancer services in rural areas has disadvantages. Bmj 320(7236): 717

Beecham, L. 1999: BMA wants presumed consent for organ donors. Bmj 319(7203): 141

Beecham 1999: BMA welcomes plans to regulate private care. Bmj 319(7222): 1390b

Dyer, C. 1996: BMA will review guidelines on PVS. Bmj 312(7033): 725-726

Bridgewater 1998: Is rationing down under upside down?. Bmj 316(7139): 1251a

Miller, D.L.; Frankland, L. 1993: BMA's evidence on specialist training. Bmj 306(6877): 587

Lewin, S.; de Gruchy, J. 1999: BMA's gold medal award to the president of the South African Medical association. Is this a travesty?. Bmj 318(7180): 396

Dyer, C. 1999: BMA's patient confidentiality rules are deemed unlawful. Bmj 319(7219): 1221

Rosenberg, M. 1995: BMA's representation of clinical and medical directors. Medical directors in Wales not represented. Bmj 310(6978): 531-532

Ikeda, M. 2000: BMAL1 and circadian rhythm. Nihon Shinkei Seishin Yakurigaku Zasshi 20(5): 203-212

Tang, D.G.; Li, L.; Zhu, Z.; Joshi, B.; Johnson, C.R.; Marnett, L.J.; Honn, K.V.; Crissman, J.D.; Krajewski, S.; Reed, J.C.; Timar, J.; Porter, A.T. 1998: BMD188, a novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases. Pathology Oncology Research: Por 4(3): 179-190

Armstrong, P.W.; Hughes, V.M. 1997: BME defines public policy in physician self-referral. New Jersey Medicine 94(12): 49-51

Purohit, T.J.; Hanning, S.M.; Wu, Z. 2018: Advances in rectal drug delivery systems. Pharmaceutical Development and Technology 23(10): 942-952

Bassingthwaighte, J.B. 1994: BMES's involvement in consortia of scientific societies. Annals of Biomedical Engineering 22(2): 127

Russell, D.H. 1996: BMETs in equipment repair depots: does the need remain?. Biomedical Instrumentation and Technology 30(6): 532-534

Zerbo, D.; Flezar, M.; Stefancic, M. 1998: BMI and Heath-Carter somatotypes of female students in Ljubljana. Collegium antropologicum 22(2): 451-463

Seidman, D.S. 1993: BMI and duration of breast feeding. Journal of Epidemiology and Community Health 47(6): 508

Luciano, A.; Piccoli, A.; Bonetti, P.; Romano, R.; Bolognani, M.; Castellarin, A.; Zoppi, G. 2001: BMI centile as an indicator of degree of obesity in childhood. La Pediatria medica e chirurgica: Medical and surgical pediatrics 23(3-4): 183-185

Petersen, T.Anne-Grete.; Rasmussen, Søren.; Madsen, M. 2002: BMI of Danish school children measured during the periods 1986/1987--1996/1997 compared to Danish measurement in 1971/1972. Ugeskrift for laeger 164(43): 5006-5010

Johnson, M. 2002: BMI--another "vital" sign?. Nasnewsletter 17(4): 12

Widhalm, K.; Schönegger, K. 1999: BMI: does it really reflect body fat mass?. Journal of Pediatrics 134(4): 522-523

De Geeter, F. 1997: BMIPP and flow tracers in myocardial hypoperfusion. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 38(7): 1171

Tadamura, E.; Tamaki, N.; Kudoh, T.; Hattori, N.; Konishi, J. 1999: BMIPP compared with PET metabolism. International Journal of Cardiac Imaging 15(1): 61-69

Taki, J.; Matsunari, I.; Nakajima, K.; Tonami, N. 1999: BMIPP compared with thallium redistribution. International Journal of Cardiac Imaging 15(1): 49-59

Franken, P.R.; Hambÿe, A.S.; De Geeter, F.W. 1999: BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. International Journal of Cardiac Imaging 15(1): 27-34

Nishimura, S.; Ohta, Y. 1999: BMIPP in angina pectoris. International Journal of Cardiac Imaging 15(1): 35-39

Knapp, F.F.; Kropp, J. 1999: BMIPP-design and development. International Journal of Cardiac Imaging 15(1): 1-9

Smith 1998: BMJ bans anniversaries. We promise our readers no more boring anniversaries. Bmj 317(7174): 1674

Davis, R.M.; Pless, B. 2001: BMJ bans "accidents". Bmj 322(7298): 1320-1321

Anonymous 1998: BMJ data. Bmj 316(7143): 1519-1520

Badrinath, P. 1998: BMJ has largely met its target for publication time for long papers. Bmj 316(7143): 1536

McConnell, J. 1999: BMJ introduces a fast track system for papers. Publication cycle. Bmj 318(7186): 808

Goldbeck-Wood; Robinson 1999: BMJ introduces a fast track system for papers. We will offer to publish exceptional papers within four weeks. Bmj 318(7184): 620

Thulesius, H. 2000: BMJ is not on the impact factor list. Lakartidningen 97(46): 5375 5378

Smith, R.; Williamson, A. 2002: BMJ journals free to the developing world. Bmj 324(7334): 380

Wahal, C.; Kumar, A.; Pyati, S. 2018: Advances in regional anaesthesia: a review of current practice, newer techniques and outcomes. Indian Journal of Anaesthesia 62(2): 94-102

Delamothe, T. 2000: BMJ set to sign with PubMed Central, JSTOR, and WorldSpace. Bmj 320(7226): 8

Kerr, M. 1999: BMJ should cover health policies of all parties in Scottish election. Bmj 318(7192): 1215

Morris 1999: BMJ should stop confusing its readers over national differences. Bmj 318(7192): 1221

Abbasi, K. 1998: BMJ to act on media abuse. Bmj 316(7126): 170

Ferriman 2000: BMJ wins an Ig nobel prize. Bmj 321(7266): 914b

Mihill, C.; Pope, N.; Hunt, L.; Cooper, G.; Fletcher, D. 1996: BMJ's embargo should not be broken. Bmj 313(7052): 305

Horgan, A. 2002: BMJ's impact factor increases by 24%. Bmj 325(7354): 8

Tobias, J.S. 1997: BMJ's present policy (sometimes approving research in which patients have not given fully informed consent) is wholly correct. Bmj 314(7087): 1111-1114

Southall, D. 1993: BMJ's press release inaccurate. Bmj 306(6892): 1617

Anonymous 2002: BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 16(5): 376-377

Papermaster, T. 1997: Government, not war, is our worst disease. Minnesota Medicine 80(4): 6-7

Sigel, M.E. 1994: BMP just following the law. Minnesota Medicine 77(1): 30-31

Cheifetz, S. 1999: BMP receptors in limb and tooth formation. Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists 10(2): 182-198

Nachaliel, N.; Re'Em-Kalma, Y.; Eshed, O.; Elias, S.; Frank, D. 1998: BMP regulates vegetal pole induction centres in early xenopus development. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 3(10): 649-658

Délot, E.èl.C.; Bahamonde, M.E.; Zhao, M.; Lyons, K.M. 2003: BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 130(1): 209-220

Bessho, K.; Carnes, D.L.; Cavin, R.; Chen, H.Y.; Ong, J.L. 1999: BMP stimulation of bone response adjacent to titanium implants in vivo. Clinical Oral Implants Research 10(3): 212-218

Majumdar, M.K.; Wang, E.; Morris, E.A. 2001: BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Journal of Cellular Physiology 189(3): 275-284

Piscione, T.D.; Yager, T.D.; Gupta, I.R.; Grinfeld, B.; Pei, Y.; Attisano, L.; Wrana, J.L.; Rosenblum, N.D. 1997: BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. American Journal of Physiology 273(6): F961-F975

Hanada, K.; Solchaga, L.A.; Caplan, A.I.; Hering, T.M.; Goldberg, V.M.; Yoo, J.U.; Johnstone, B. 2001: BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. Journal of Cellular Biochemistry 81(2): 284-294

Mayr-Wohlfart, U.; Kessler, S.; Knöchel, W.; Puhl, W.; Günther, K.P. 2001: BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. Journal of Bone and Joint Surgery. British Volume 83(1): 144-147

Boskey, A.L.; Paschalis, E.P.; Binderman, I.; Doty, S.B. 2002: BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures. Journal of Cellular Biochemistry 84(3): 509-519

Francis-West, P.H.; Parish, J.; Lee, K.; Archer, C.W. 1999: BMP/GDF-signalling interactions during synovial joint development. Cell and Tissue Research 296(1): 111-119

Bahamonde, M.E.; Lyons, K.M. 2001: BMP3: to be or not to be a BMP. Journal of Bone and Joint Surgery. American Volume 83-A Suppl 1(Part 1): S56-S62

Wright, V.; Peng, H.; Usas, A.; Young, B.; Gearhart, B.; Cummins, J.; Huard, J. 2002: BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Molecular Therapy: the Journal of the American Society of Gene Therapy 6(2): 169-178

Machado, R.D.; Pauciulo, M.W.; Thomson, J.R.; Lane, K.B.; Morgan, N.V.; Wheeler, L.; Phillips, J.A.; Newman, J.; Williams, D.; Galiè, N.; Manes, A.; McNeil, K.; Yacoub, M.; Mikhail, G.; Rogers, P.; Corris, P.; Humbert, M.; Donnai, D.; Martensson, G.; Tranebjaerg, L.; Loyd, J.E.; Trembath, R.C.; Nichols, W.C. 2001: BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. American Journal of Human Genetics 68(1): 92-102

Lane, J.M. 2001: BMPs: why are they not in everyday use?. Journal of Bone and Joint Surgery. American Volume 83-A Suppl 1(Part 2): S161-S163

Mathers, J.C. 1997: BMR multiples as a basis for estimating energy needs. British Journal of Nutrition 78(6): 1039-1040

Hobman, J.L. 2001: BMRI-2, Rossendorf/Dresden, Germany (30 August - 1 September 2000). Environmental Microbiology 3(2): 145-148

Anonymous 1994: BMS (Bristol's Southmead Hospital) allows fewer to manage more while using less. Health estate journal: journal of the Institute of Hospital Engineering 48(4): 15-18

Anonymous 2001: BMS and Exelixis target tumor suppression pathways. Expert review of anticancer therapy 1(2): 167

Hulpke-Wette, M.; Buchhorn, R. 2002: BMS-193884 and BMS-207940 Bristol-Myers Squibb. Current Opinion in Investigational Drugs 3(7): 1057-1061

Mackay, K.B. 2001: BMS-204352 (Bristol Myers Squibb). Current Opinion in Investigational Drugs 2(6): 820-823

Witherell, G. 2001: BMS-232632 (Novartis/Bristol-Myers Squibb). Current Opinion in Investigational Drugs 2(3): 340-347

Gaylord, G. 2000: BMS-232632, a new protease inhibitor, is taken once daily. Positive Living 9(6): 22

Lee, F.Y.; Borzilleri, R.; Fairchild, C.R.; Kim, S.H.; Long, B.H.; Reventos-Suarez, C.; Vite, G.D.; Rose, W.C.; Kramer, R.A. 2001: BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1429-1437

Poulaki, V. 2002: BMS-275291. Bristol-Myers Squibb. Current Opinion in Investigational Drugs 3(3): 500-504

Burke, J.R.; Pattoli, M.A.; Gregor, K.R.; Brassil, P.J.; MacMaster, J.F.; McIntyre, K.W.; Yang, X.; Iotzova, V.S.; Clarke, W.; Strnad, J.; Qiu, Y.; Zusi, F.C. 2003: BMS-345541 is a highly selective inhibitor of i kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. Journal of Biological Chemistry 278(3): 1450-1456

Gordon, K.A.; Pfaller, M.A.; Jones, R.N. 2002: BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000). Journal of Antimicrobial ChemoTherapy 49(5): 851-855

Sardella, A.; Carrassi, A. 2001: BMS: S for syndrome or S for symptom? a reappraisal of the burning mouth syndrome. Minerva Stomatologica 50(7-8): 241-246

Hoogerbrugge, P.M.; Vossen, J.M. 1995: BMT for isolated central nervous system relapse in children with ALL. Bone Marrow Transplantation 16(6): 859-860

Burt, R.K. 1997: BMT for severe autoimmune diseases: an idea whose time has come. Oncology 11(7): 1001-1014; 1017; Discussion: 1018-1024

Ladenstein, R.; Peters, C.; Matthes-Martin, S.; Rosenmayr, A.; Höcker, P.; Pötter, R.; Pötschinger, U.; Gadner, H. 1996: BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment. Bone Marrow Transplantation 18(Suppl 2): 86-91

Busca, A.; Uderzo, C. 2000: BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy. Hematology 5(1): 53-67

Tremblay, G. 1999: BN 52021 decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. Mediators of Inflammation 8(3): 181-182

Grino, J.M. 1994: BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation. Annals of Internal Medicine 121(5): 345-347

Chen, Z.; Jiao, H.; Hirsch, A.; Thiel, W. 2001: BN-doped fullerenes: an NICS characterization. Journal of Organic Chemistry 66(10): 3380-3383

Debek, W.; Chyczewski, L.; Oldhafer, K.J. 1999: BN52021 inhibits activation of peritoneal mast cells caused by hemorrhage and blood volume restoration. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 50(4): 259-267

Anonymous 1978: BNA survey: firms expand benefits, reject national health. Business Insurance 12(18): 20

Imanishi, T.; Obika, S. 2002: BNAs: novel nucleic acid analogs with a bridged sugar moiety. Chemical Communications 16: 1653-1659

Lüdemann, L.; Matzen, T.; Schmidt, R.; Scobel, W. 1996: BNCT as a boost for fast neutron therapy?. Bulletin du Cancer. Radiotherapie: Journal de la Societe Francaise du Cancer: Organe de la Societe Francaise de Radiotherapie Oncologique 83 Suppl: 198s-200s

Henriksson, R.; Persson, L. 2002: BNCT--neutron radiotherapy of brain tumors. Lakartidningen 99(4): 289-290

Ramey, J. 2000: Evaluation of periventricular-intraventricular hemorrhage in premature infants using cranial ultrasounds. Neonatal Network: Nn 19(7): 31-37

Hanrahan, K.S.; Kleiber, C.; Berends, S. 2000: Saline for peripheral intravenous locks in neonates: evaluating a change in practice. Neonatal Network: Nn 19(2): 19-24

Baker, R. 1994: BNHS (British National Health Service) age rationing: a riposte to Bates. Health Care Analysis: Hca: Journal of Health Philosophy and Policy 2(1): 39-41

Lowenstein, D.I.; Lowenstein, D.I. 2001: BNL accelerator-based radiobiology facilities. Physica Medica: Pm: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics 17(Suppl 1): 26-29

Hart, G.; Jarritt, P.; Cosgriff, P. 1997: BNMS gamma camera/data processor system specification questionnaire. Nuclear Medicine Communications 18(2): 95-97

Bruneau, B.G.; Piazza, L.A.; de Bold, A.J. 1997: BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. American Journal of Physiology 273(6): H2678-H2686

Burger, M.R.; Burger, A.J. 2001: BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Current Opinion in Investigational Drugs 2(7): 929-935

Lader, E. 2003: BNP levels had high sensitivity but moderate specificity for detecting congestive heart failure in the emergency department. Acp Journal Club 138(1): 23

Grantham, J.A.; Burnett, J.C. 1997: BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation 96(2): 388-390

Cowie, M.R. 2000: BNP: soon to become a routine measure in the care of patients with heart failure?. Heart 83(6): 617-618

Wiersbitzky, S.; Burtzlaff, C.; Weinke, I.; Wiersbitzky, H.; Herrmann, H. 1993: BNS epilepsy after the second triple (DPT) vaccination?. Kinderarztliche Praxis 61(6): 229-231

Kõks, S.; Soosaar, A.; Võikar, V.; Bourin, M.; Vasar, E. 1999: BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides 33(1): 63-69

Ketter, J. 1994: BOD approves plan to increase staff RN participation. as i see it. American Nurse 26(6): 6

Taylor, N.J.; Baddeley, H.; Goodchild, K.A.; Powell, M.E.; Thoumine, M.; Culver, L.A.; Stirling, J.J.; Saunders, M.I.; Hoskin, P.J.; Phillips, H.; Padhani, A.R.; Griffiths, J.R. 2001: BOLD MRi of human tumor oxygenation during carbogen breathing. Journal of Magnetic Resonance Imaging: Jmri 14(2): 156-163

Dunn, J.F.; Zaim-Wadghiri, Y.; Pogue, B.W.; Kida, I. 1998: BOLD MRi vs. NIR spectrophotometry. will the best technique come forward?. Advances in Experimental Medicine and Biology 454: 103-113

Landuyt, W.; Hermans, R.; Bosmans, H.; Sunaert, S.; Béatse, E.; Farina, D.; Meijerink, M.; Zhang, H.; Van Den Bogaert, W.; Lambin, P.; Marchal, G. 2001: BOLD contrast fMRi of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. European Radiology 11(11): 2332-2340

Nakai, T.; Matsuo, K.; Kato, C.; Okada, T.; Moriya, T.; Isoda, H.; Takehara, Y.; Sakahara, H. 2001: BOLD contrast on a 3 T magnet: detectability of the motor areas. Journal of Computer Assisted Tomography 25(3): 436-445

Mohamed, F.B.; Pinus, A.B.; Faro, S.H.; Patel, D.; Tracy, J.I. 2002: BOLD fMRi of the visual cortex: quantitative responses measured with a graded stimulus at 1.5 Tesla. Journal of Magnetic Resonance Imaging: Jmri 16(2): 128-136

Nakada, T. 1999: BOLD functional MRI: practical pitfalls. Rinsho Shinkeigaku 39(1): 39-41

Song, A.W.; Fichtenholtz, H.; Woldorff, M. 2002: BOLD signal compartmentalization based on the apparent diffusion coefficient. Magnetic Resonance Imaging 20(7): 521-525

Nathan, F.E.; Berd, D.; Sato, T.; Shield, J.A.; Shields, C.L.; De Potter, P.; Mastrangelo, M.J. 1997: BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. Journal of Experimental and Clinical Cancer Research: Cr 16(2): 201-208

Wacker, C.M.; Bock, M.; Hartlep, A.W.; Bauer, W.R.; van Kaick, G.; Pfleger, S.; Ertl, G.; Schad, L.R. 1999: BOLD-MRi in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. Magma 8(1): 48-54

Bohning, D.E.; Shastri, A.; Wassermann, E.M.; Ziemann, U.; Lorberbaum, J.P.; Nahas, Z.; Lomarev, M.P.; George, M.S. 2000: BOLD-f MRi response to single-pulse transcranial magnetic stimulation (TMS). Journal of Magnetic Resonance Imaging: Jmri 11(6): 569-574

Wilkinson, R.M. 1998: BOMB! Making a difference during a hospital emergency. American Journal of Nursing 98(10): 68-69

Germà-Lluch, J.R.; Garcia del Muro, X.; Tabernero, J.M.; Sánchez, M.; Aparicio, J.; Alba, E.; Barnadas, A. 1999: BOMP/EPi intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG). Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(3): 289-293

Johnson, C.; Macaluso, M. 1998: BONENT to offer certification for LPNs, LVNs in nephrology. Nephrology News and Issues 12(11): 19

Cosgrove, D.A.; Kenny, P.W. 1996: BOOMSLANG: a program for combinatorial structure generation. Journal of Molecular Graphics 14(1): 1-5 23

Verberckmoes, R.; Verbeken, E.; Verschakelen, J.; Vanrenterghem, Y. 1996: BOOP (bronchiolitis obliterans organizing pneumonia) after renal transplantation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 11(9): 1862-1863

Gupta, P.R.; Joshi, N.; Khangarot, S. 1999: BOOP presenting as pseudo-lymphadenopathy. Indian Journal of Chest Diseases and Allied Sciences 41(4): 235-240

Zhu, Q.; Chen, D. 2017: Advances in relationship between PTEN and myocardial fibrosis. Zhonghua Bing Li Xue Za Zhi 46(12): 880-883

Belykh, S.I. 1994: BOP-polymer implants for fixation of tubular bones and replacement of osseous tissue defects. Meditsinskaia Tekhnika 2: 9-11

Taigman, M.; Forster, J. 2002: BORSTAR: border patrol EMS. Emergency Medical Services 31(1): 40

Gyarmati, G.; Kadoya, H.; Moon, J.-Y.; Burford, J.L.; Ahmadi, N.; Gill, I.S.; Hong, Y.-K.; Dér, B.ál.; Peti-Peterdi, J.án. 2018: Advances in Renal Cell Imaging. Seminars in Nephrology 38(1): 52-62

Fishman, L.M.; Anderson, C.; Rosner, B. 2002: BOTOX and physical therapy in the treatment of piriformis syndrome. American Journal of Physical Medicine and Rehabilitation 81(12): 936-942

Carruthers, J.; Carruthers, A. 2001: BOTOX use in the mid and lower face and neck. Seminars in Cutaneous Medicine and Surgery 20(2): 85-92

Mendez-Eastman, S.K. 2000: BOTOX: a review. Plastic Surgical Nursing: Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses 20(2): 60

Beutler, E.; Gelbart, T. 1998: Hematologically important mutations: Gaucher disease. Blood Cells Molecules and Diseases 24(1): 2-8

Scribner, B.H. 2000: BP control, dialysis adequacy, and vitamin C. Seminars in Dialysis 13(3): 204

Anonymous 2002: BP drug approved for heart failure. Health News 8(10): 9

Robischon, T. 1983: BP monitoring on the move. Cvp 11(4): 27-8 30 33

Preti, A. 2000: BP-897 Bioprojet. Current Opinion in Investigational Drugs 1(1): 110-115

Nelson, D.; Mayo, R.; Moody, P.E. 2000: BP: developing excellence in the global enterprise. Hospital Materiel Management Quarterly 22(1): 68-70

Seiwerth, S.; Sikiric, P.; Grabarevic, Z.; Zoricic, I.; Hanzevacki, M.; Ljubanovic, D.; Coric, V.; Konjevoda, P.; Petek, M.; Rucman, R.; Turkovic, B.; Perovic, D.; Mikus, D.; Jandrijevic, S.; Medvidovic, M.; Tadic, T.; Romac, B.; Kos, J.; Peric, J.; Kolega, Z. 1997: BPC 157's effect on healing. Journal of Physiology Paris 91(3-5): 173-178

Maguire, D.; Power, C.; McAnena, O.J. 2000: BPCF vs HCF. Surgical Endoscopy 14(10): 968-969

Lombardo, G.T. 1997: BPD and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 36(6): 719-720

Scopinaro 2000: BPD and prader willi syndrome. Obesity Surgery 10(2): 182

Anonymous 1999: BPH survey reveals confusion about condition that strikes 80% of men by age 80. Comprehensive Therapy 25(1): 57-58

Knutson, T.; Edlund, C.; Fall, M.; Dahlstrand, C. 2001: BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma. Neurourology and Urodynamics 20(3): 237-247

McConnell, J.D.; Goldwasser, B.; Marberger, M. 1995: BPH: what really works?. Contemporary Urology 7(4): 76-80; 82 84 Passim

Kumararatne, D.S. 1998: BPL plasma products: new source, enhanced products. Hospital Medicine 59(12): 936-937

Hoffer, A. 2003: BPM: antidote to inefficiency. Business process management serves as a foundation for effective workflow automation in healthcare. Health Management Technology 24(1): 40-43

Watson, M.S. 1999: BPMC drops hCG patent infringement lawsuit against Kaiser. Genetics in Medicine: Official Journal of the American College of Medical Genetics 1(3): 120

Jerva, M. 2001: BPR (business process redesign) and systems analysis and design: making the case for integration. Topics in Health Information Management 21(4): 30-37

Silverstein, M.L.; Mavrolefteros, G.; Close, D. 1997: BPRS syndrome scales during the course of an episode of psychiatric illness. Journal of Clinical Psychology 53(5): 455-458

Landis, N.T. 2000: BPS roster of certified pharmacists nears 3000 mark. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 57(3): 208

Bandos, I.A.; de Azcárraga, J.A.; Izquierdo, J.M.; Lukierski, J. 2001: BPS states in M theory and twistorial constituents. Physical Review Letters 86(20): 4451-4454

Lisi, D.M. 1997: Ethical issues for pharmacists in managed care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 54(9): 1041-1042; 1045

Grouazel, S.; Perez, J.; Astier, J.P.; Bonneté, F.; Veesler, S. 2002: BPTi liquid-liquid phase separation monitored by light and small angle X-ray scattering. Acta Crystallographica. Section D Biological Crystallography 58(Part 10 Pt 1: 1560-1563

Büyükgebiz, O.; Aktan, A.O.; Haklar, G.; Yalçin, A.S.; Yeğen, C.; Yalin, R.; Ercan, Z.S. 1996: BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 9(3): 201-207

Zamora, M.A.; Dempsey, E.C.; Walchak, S.J.; Stelzner, T.J. 1993: BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 9(4): 429-433

Koyama, Y.; Takemura, M.; Fujiki, K.; Ishikawa, N.; Shigenaga, Y.; Baba, A. 1999: BQ788, an endothelin ET(B) receptor antagonist, attenuates stab wound injury-induced reactive astrocytes in rat brain. Glia 26(3): 268-271

Rogers, J. 1977: BQA policy on medical care evaluation studies, JCAH policy on PSRO MCEs, AMRA response to reimbursement transmittal. Medical Record News 48(1): 60-64

Järvinen, S.H. 1991: BRACS--a method for cephalometric diagnosis and orthodontic treatment planning. Biometric radiographic analysis of the craniofacial skeleton. Deutsche Zahn- Mund- und Kieferheilkunde Mit Zentralblatt 79(1): 23-29

Feng-Quan, X.; Tao, Y.; Yong, H. 2016: Advances in researches of balantidiosis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 28(3): 345-348

Nenov, V.I.; Buxey, F.; Yamaguchi, Y. 1999: BRAVO/TeleTrend: a comprehensive WWW-based neuromonitoring system for the neurosurgery ICU. Studies in Health Technology and Informatics 62: 228-234

Anonymous 1996: BRC criteria revised. Environmental Health Perspectives 104(8): 824

Lancaster; Carney; Futreal 1997: BRCA 1 and 2--A Genetic Link to Familial Breast and Ovarian Cancer. Medscape Women's Health 2(2): 7

Goelen, G.; Rigo, A.; Bonduelle, M.; De Grève, J. 1999: BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients. Annals of the new York Academy of Sciences 889: 240-243

Zimmerman, V.L. 2002: BRCA gene mutations and cancer. American Journal of Nursing 102(8): 28-36

Healy, B. 1997: BRCA genes--bookmaking, fortunetelling, and medical care. New England Journal of Medicine 336(20): 1448-1449

Foulkes, W.D.; Wong, N.; Brunet, J.S.; Narod, S.A. 1998: BRCA mutations and survival in breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(9): 3206-3208

Robson, M.; Gilewski, T.; Haas, B.; Levin, D.; Borgen, P.; Rajan, P.; Hirschaut, Y.; Pressman, P.; Rosen, P.P.; Lesser, M.L.; Norton, L.; Offit, K. 1998: BRCA-associated breast cancer in young women. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(5): 1642-1649

Anonymous 1998: BRCA1 (breast cancer type 1). Tumor suppressor gene. Bulletin du Cancer 85(10): 833

Menczer, J.; Theodor, L.; Friedman, E. 1997: BRCA1 185delAG mutation in a non-Ashkenazi Jewish woman with early-onset breast and ovarian cancer. American Journal of Obstetrics and Gynecology 176(3): 731

Scholl, T.; Pyne, M.T.; Russo, D.; Ward, B.E. 1999: BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site. American Journal of Medical Genetics 85(2): 113-116

Johnson, N.C.; Kruk, P.A. 2002: BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells. Cancer Cell International 2(1): 7

Fukutomi; Ushijima; Inoue; Akashi-Tanaka; Nanasawa; Tsuda 1997: BRCA1 and BRCA2 Germline Mutations in Japanese with Hereditary Breast Cancer Families. Breast Cancer 4(4): 256-258

Bishop, D.T. 1999: BRCA1 and BRCA2 and breast cancer incidence: a review. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(Suppl 6): 113-119

Farghaly, S.A. 1998: BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications. American Journal of Obstetrics and Gynecology 179(4): 1101-1102

Fasouliotis, S.J.; Schenker, J.G. 2000: BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management. Obstetrical and Gynecological Survey 55(6): 373-384

Palmieri, G.; Palomba, G.; Cossu, A.; Pisano, M.; Dedola, M.F.; Sarobba, M.G.; Farris, A.; Olmeo, N.; Contu, A.; Pasca, A.; Satta, M.P.; Persico, I.; Carboni, A.A.; Cossu-Rocca, P.; Contini, M.; Mangion, J.; Stratton, M.R.; Tanda, F. 2002: BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(12): 1899-1907

Saxena, S.; Szabo, C.I.; Chopin, S.; Barjhoux, L.; Sinilnikova, O.; Lenoir, G.; Goldgar, D.E.; Bhatanager, D. 2002: BRCA1 and BRCA2 in Indian breast cancer patients. Human Mutation 20(6): 473-474

Lee, W.H.; Boyer, T.G. 2001: BRCA1 and BRCA2 in breast cancer. Lancet 358 Suppl: S5

Garvin, A.M.; Attenhofer-Haner, M.; Scott, R.J. 1997: BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. Journal of Medical Genetics 34(12): 990-995

Shih, H.A.; Couch, F.J.; Nathanson, K.L.; Blackwood, M.A.; Rebbeck, T.R.; Armstrong, K.A.; Calzone, K.; Stopfer, J.; Seal, S.; Stratton, M.R.; Weber, B.L. 2002: BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(4): 994-999

Schubert, E.L.; Mefford, H.C.; Dann, J.L.; Argonza, R.H.; Hull, J.; King, M.C. 1997: BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genetic Testing 1(1): 41-46

Sibille-Hoang, C.; Froment, O.; Joos de ter Beerst, A.; Lepiece, V.; Huberlant, G.; Blauwaert, G.; Vindevoghel, A.; Canon, J.L.; Gillerot, Y. 1998: BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 7(Suppl 1): S3-S5

Tereschenko, I.V.; Basham, V.M.; Ponder, B.A.J.; Pharoah, P.D.P. 2002: BRCA1 and BRCA2 mutations in Russian familial breast cancer. Human Mutation 19(2): 184

Basham, V.M.; Lipscombe, J.M.; Ward, J.M.; Gayther, S.A.; Ponder, B.A.J.; Easton, D.F.; Pharoah, P.D.P. 2002: BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Research: Bcr 4(1): R2

Shih, H.A.; Nathanson, K.L.; Seal, S.; Collins, N.; Stratton, M.R.; Rebbeck, T.R.; Weber, B.L. 2000: BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(11): 4259-4264

Ottini, L.; D'Amico, C.; Noviello, C.; Lauro, S.; Lalle, M.; Fornarini, G.; Colantuoni, O.A.; Pizzi, C.; Cortesi, E.; Carlini, S.; Guadagni, F.; Bianco, A.R.; Frati, L.; Contegiacomo, A.; Mariani-Costantini, R. 2000: BRCA1 and BRCA2 mutations in central and southern Italian patients. Breast Cancer Research: Bcr 2(4): 307-310

Koul, A..; Malander, S..; Loman, N..; Pejovic, T..; Heim, S..; Willen, R..; Johannsson, O..; Olsson, H..; Ridderheim, M..; Borg Å, Å. 2000: BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 10(4): 289-295

Bernard-Gallon, D.J.; Déchelotte, P.; Vissac, C.; Aunoble, B.; Cravello, L.; Malpuech, G.; Bignon, Y.J. 2001: BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite. Breast Cancer Research: Bcr 3(1): 61-65

Duncan, J.A.; Reeves, J.R.; Cooke, T.G. 1998: BRCA1 and BRCA2 proteins: roles in health and disease. Molecular Pathology: Mp 51(5): 237-247

Zhi, X.; Szabo, C.; Chopin, S.; Suter, N.; Wang, Q.-S.; Ostrander, E.A.; Sinilnikova, O.M.; Lenoir, G.M.; Goldgar, D.; Shi, Y.-R. 2002: BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Human Mutation 20(6): 474

Dagan, E.; Gershoni-Baruch, R. 1997: BRCA1 and BRCA2--breast cancer susceptibility genes. Harefuah 133(10): 455-457

Burke, W.; Press, N.; Pinsky, L. 1999: BRCA1 and BRCA2: a small part of the puzzle. Journal of the National Cancer Institute 91(11): 904-905

Scherneck, S.; Hofmann, W. 1999: BRCA1 and BRCA2: mutations and other genetic changes--practical relevance. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 70(4): 373-379

Foulkes, W.D. 1998: BRCA1 and BRCA2: penetrating the clinical arena. Lancet 352(9137): 1325-1326

Lee, E.Y.-H.P. 2002: BRCA1 and Chk1 in G2/M checkpoint: a new order of regulation. Cell Cycle 1(3): 178-180

Fearon, E.R. 2000: BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?. Journal of the National Cancer Institute 92(7): 515-517

Larsen, C.J. 2000: BRCA1 and cancer: a new lead. Bulletin du Cancer 87(10): 693-694

Eisinger, F.; Noguès, C.; Birnbaum, D.; Jacquemier, J.; Sobol, H. 1998: BRCA1 and medullary breast cancer. JAMA 280(14): 1227-1228

Gardner, K.; Liu, E.T. 2001: BRCA1 function in T lymphocytes: a cellular specificity of a different kind. Breast Cancer Research: Bcr 3(1): 11-13

Ding, X.; Lang, J. 2000: BRCA1 gene mutations in early-onset breast cancer. Zhonghua Yi Xue Za Zhi 80(2): 111-113

Vijg, J.; Perls, T.; Franceschi, C.; van Orsouw, N.J. 2001: BRCA1 gene sequence variation in centenarians. Annals of the new York Academy of Sciences 928: 85-96

Crosbie, A.; Brewer, C.; Campbell, K.; MacKay, J. 1998: BRCA1 gene testing for breast and ovarian cancer in one family. British Journal of Nursing 7(22): 1386-1392

Hadjisavvas, A.; Neuhausen, S.L.; Hoffman, M.D.; Adamou, A.; Newbold, R.F.; Kyriacou, K.C.; Christodoulou, C.G. 2001: BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history. Anticancer Research 21(5): 3307-3311

Valarmathi, M.T.; A, A.; Deo, S.S.V.; Shukla, N.K.; Das, S.N. 2003: BRCA1 germline mutations in Indian familial breast cancer. Human Mutation 21(1): 98-99

Frankish, H. 2001: BRCA1 has a pivotal role in repairing DNA. Lancet 357(9269): 1678

Aprelikova, O.; Pace, A.J.; Fang, B.; Koller, B.H.; Liu, E.T. 2001: BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. Journal of Biological Chemistry 276(28): 25647-25650

Meng, Q.H.; Yuan, R.Q.; Goldberg, I.D.; Rosen, E.M.; Fan, S.J. 2001: BRCA1 is differentially expressed in human tumor cells. Shi Yan Sheng Wu Xue Bao 34(1): 55-64

Bernard-Gallon, D.J.; Peffault de Latour, M.; De Oliveira, F.; Rio, P.; Hizel, C.; Favy, D.; Bignon, Y.J. 1998: BRCA1 is localized in ductal secretions of normal breast tissues: Detection by antibodies raised against the amino terminus of BRCA1 (K-18). International Journal of Cancer 77(5): 803-806

Konstantopoulou, I.; Kroupis, C.; Ladopoulou, A.; Pantazidis, A.; Boumba, D.; Lianidou, E.S.; Petersen, M.B.; Florentin, L.; Chiotellis, E.; Nounesis, G.; Efstathiou, E.; Skarlos, D.; Tsionou, C.; Fountzilas, G.; Yannoukakos, D. 2000: BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Human Mutation 16(3): 272-273

Yamashita, Y.; Sagawa, T.; Fujimoto, T.; Sugawara, T.; Yamada, H.; Hoshi, N.; Sakuragi, N.; Ishioka, C.; Fujimoto, S. 1999: BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening. Breast Cancer Research and Treatment 58(1): 11-17

Petty, E.M.; Killeen, A.A. 1997: BRCA1 mutation testing: controversies and challenges. Clinical Chemistry 43(1): 6-8

Whitmore, S.E. 1997: BRCA1 mutations and survival in women with ovarian cancer. New England Journal of Medicine 336(17): 1254-1255; Author Reply 1256-1257

Shushan, A.; Abeliovich, D.; Peretz, T.; Weinberg, N.; Paltiel, O. 1997: BRCA1 mutations in women with ovarian cancer. JAMA 277(12): 963

Struewing, J.P.; Tarone, R.E.; Brody, L.C.; Li, F.P.; Boice, J.D. 1996: BRCA1 mutations in young women with breast cancer. Lancet 347(9013): 1493

Kumar, A.; Knott, C.; Kuus-Reichel, K.; Saedi, M.S. 1999: BRCA1 partially reverses the transforming activity of the ras oncogene. Neoplasia 1(5): 417-423

Xue, L.; Jian-Rong, D.; Yun-Tian, X. 2017: Advances in researches of biogenic molluscicides. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 29(1): 122-125

Arver, B.; Claro, A.; Langerød, A.; Børresen-Dale, A.L.; Lindblom, A. 1999: BRCA1 screening in patients with a family history of breast or ovarian cancer. Genetic Testing 3(2): 223-226

Stoppa-Lyonnet, D.; Laurent-Puig, P.; Essioux, L.; Pagès, S.; Ithier, G.; Ligot, L.; Fourquet, A.; Salmon, R.J.; Clough, K.B.; Pouillart, P.; Bonaïti-Pellié, C.; Thomas, G. 1997: BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. American Journal of Human Genetics 60(5): 1021-1030

Schneider, K.A.; Kieffer, S.A.; Patenaude, A.F. 2000: BRCA1 testing and informed consent in a woman with mild retardation. Journal of Genetic Counseling 9(5): 411-416

Couch, F.J.; Hartmann, L.C. 1998: BRCA1 testing--advances and retreats. JAMA 279(12): 955-957

Takimoto, R.; MacLachlan, T.K.; Dicker, D.T.; Niitsu, Y.; Mori, T.; el-Deiry, W.S. 2002: BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. Cancer Biology and Therapy 1(2): 177-186

Carter, R.F. 2001: BRCA1, BRCA2 and breast cancer: a concise clinical review. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 24(3): 147-157

Lynch, H.T.; Watson, P. 1998: BRCA1, pathology, and survival. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(2): 395-396

Collins, F.S. 1996: BRCA1--lots of mutations, lots of dilemmas. New England Journal of Medicine 334(3): 186-188

Brodie, S.G.; Deng, C.X. 2001: BRCA1-associated tumorigenesis: what have we learned from knockout mice?. Trends in Genetics: Tig 17(10): S18-S22

Offit, K. 1996: BRCA1. a new marker in the management of patients with breast cancer?. Cancer 77(4): 599-601

Eeles, R.; Kadouri, L. 1999: BRCA1/2 carriers and endocrine risk modifiers. Endocrine-Related Cancer 6(4): 521-528

Chen, W.Y.; Garber, J.E.; Higham, S.; Schneider, K.A.; Davis, K.B.; Deffenbaugh, A.M.; Frank, T.S.; Gelman, R.S.; Li, F.P. 2002: BRCA1/2 genetic testing in the community setting. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(22): 4485-4492

Formenti, S.C.; Preston-Martin, S.; Haffty, B.G. 2000: BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(5): 1159-1160

Turner, B.C.; Glazer, P.M.; Haffty, B.G. 1999: BRCA1/BRCA2 in breast-conserving therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(11): 3689

Gilbert, F.; Dabney, M.K.; Diemer, K.; Ludwig, S.; Rosenthal, G.; Osborne, M.P. 1997: BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women. Annals of the new York Academy of Sciences 833: 198-203

Paterson, J.W. 1998: BRCA1: a review of structure and putative functions. Disease Markers 13(4): 261-274

Haber, D. 2000: BRCA1: an emerging role in the cellular response to DNA damage. Lancet 355(9221): 2090-2091

Ross, D.W. 1997: BRCA1: genetic testing and hereditary breast and ovarian cancer. Archives of Pathology and Laboratory Medicine 121(7): 754-755

Reynolds, T. 2001: BRCA1: lessons learned from the breast cancer gene. Journal of the National Cancer Institute 93(16): 1200-1202

Singer, M.E.; Cebul, R.D. 1997: BRCA1: to test or not to test, that is the question. Health Matrix 7(1): 163-185

Buller, R.E. 2000: BRCA1: what do we know? what do we think we know? what do we really need to know?. Gynecologic Oncology 76(3): 291-293

Auranen, A.; Spurdle, A.B.; Chen, X.; Lipscombe, J.; Purdie, D.M.; Hopper, J.L.; Green, A.; Healey, C.S.; Redman, K.; Dunning, A.M.; Pharoah, P.D.; Easton, D.F.; Ponder, B.A.J.; Chenevix-Trench, G.; Novik, K.L. 2003: BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk. International Journal of Cancer 103(3): 427-430

Orelli, B.J.; Bishop, D.K. 2001: BRCA2 and homologous recombination. Breast Cancer Research: Bcr 3(5): 294-298

Boyd, J. 1996: BRCA2 as a low-penetrance cancer gene. Journal of the National Cancer Institute 88(19): 1408-1409

Qiao, Y.; Chen, P.; Shi, H.; Zhao, G.; Wu, D. 2002: BRCA2 gene mutation detection in hereditary ovarian cancer tissues. Zhonghua Fu Chan Ke Za Zhi 37(6): 349-351

Armakolas, A.; Ladopoulou, A.; Konstantopoulou, I.; Pararas, B.; Gomatos, I.P.; Kataki, A.; Konstadoulakis, M.M.; Stathopoulos, G.P.; Markopoulos, C.; Leandros, E.; Gogas, I.; Yannoukakos, D.; Androulakis, G. 2002: BRCA2 gene mutations in Greek patients with familial breast cancer. Human Mutation 19(1): 81-82

Díez, O.; Cortés, J.; Domènech, M.; Pericay, C.; Brunet, J.; Alonso, C.; Baiget, M. 2000: BRCA2 germ-line mutations in Spanish male breast cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(1): 81-84

Plaschke, J.; Commer, T.; Jacobi, C.; Schackert, H.K.; Chang-Claude, J. 2000: BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease. Journal of Medical Genetics 37(9): E17

Kwiatkowska, E.; Teresiak, M.; Lamperska, K.M.; Karczewska, A.; Breborowicz, D.; Stawicka, M.; Godlewski, D.; Krzyzosiak, W.J.; Mackiewicz, A. 2001: BRCA2 germline mutations in male breast cancer patients in the Polish population. Human Mutation 17(1): 73

Campos, B.; Diez, O.; Domènech, M.; Baena, M.; Pericay, C.; Balmaña, J.; del Rio, E.; Sanz, J.; Alonso, C.; Baiget, M. 2001: BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(12): 1699-1703

Nelson, N.J. 1998: BRCA2 research is on a fast track to the clinic. Journal of the National Cancer Institute 90(20): 1502-1504

Schwab, M.; Claas, A.; Savelyeva, L. 2002: BRCA2: a genetic risk factor for breast cancer. Cancer Letters 175(1): 1-8

Boyd, J. 2001: BRCA: the breast, ovarian, and other cancer genes. Gynecologic Oncology 80(3): 337-340

Berry, D.A.; Iversen, E.S.; Gudbjartsson, D.F.; Hiller, E.H.; Garber, J.E.; Peshkin, B.N.; Lerman, C.; Watson, P.; Lynch, H.T.; Hilsenbeck, S.G.; Rubinstein, W.S.; Hughes, K.S.; Parmigiani, G. 2002: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(11): 2701-2712

Schomburg, I.; Chang, A.; Schomburg, D. 2002: BRENDA, enzyme data and metabolic information. Nucleic Acids Research 30(1): 47-49

Billard, C.; Livet, M.O.; Motte, J.; Vallée, L.; Gillet, P.; Galloux, A.; Piller, A.G.; Vol, S. 2001: BREV: a new clinical scale for the evaluation of cognitive function in school-age and preschool-age children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 8(5): 545-552

Billard, C.; Gillet, P.; Galloux, A.; Piller, A.G.; Livet, M.O.; Motte, J.; Vallée, L.; Vol, S. 2000: BREV: an assessment battery for cognitive deficits in children 4 to 9 years old. Results of a normative study in 500 children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 7 Suppl. 2: 128s-130s

Kohlmann, T. 2001: BRFSS and beyond: methodological quality of the measures from the Behavioral Risk Factor Surveillance System. Sozial- und Praventivmedizin 46(Suppl 1): S1-S2

Vincent, A.L.; Bradham, D.; Hoecherl, S.; McTague, D. 1994: BRFSS-based survey of the Florida public on restaurant smoking. Journal of the Florida Medical Association 81(3): 171-173

Reid; Kirkpatrick; Gizis; Liebert 1999: BRI 0021-0214: Another Surprise at the Bottom of the Main Sequence. Astrophysical journal 527(2): L105-L107

Nam, K.H.; Li, J. 2002: BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling. Cell 110(2): 203-212

Muelleman, R.L.; Feighny, K.M.; Bozard, C.C.; Bergin, L. 1995: BRIDGE: a community-based advocacy program for battered women in the emergency department. Missouri Medicine 92(11): 685-687

Köhler, L.; Eklund, L. 2002: BRIMHEALTH. a successful experience in Nordic-Baltic co-operation in public health training. European Journal of Public Health 12(2): 152-154

Fabbri, G.; Maggioni, A.P. 2000: BRING-UP 2: presentation of the study. Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 1(8): 1043-1046

Stokes, T. 2000: BRInging light to hormone receptor activation. Trends in Plant Science 5(9): 366

Llor, X.; Serfas, M.S.; Bie, W.; Vasioukhin, V.; Polonskaia, M.; Derry, J.; Abbott, C.M.; Tyner, A.L. 1999: BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(7): 1767-1777

Yamada, K. 1993: BRM and drug combination therapy of HIV carriers. Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 343-350

Bredderman, P.J.; Wojcik, J.; Flake, D. 1988: BRS Colleague MEDLINE end user training follow-up survey. Medical Reference Services Quarterly 7(3): 15-34

Chung; Kim 1990: BRS analysis of supersymmetrized Zamolodchikov's spin-3 algebra. Physical Review. D Particles and Fields 41(4): 1336-1338

Kim; Park; Cho 1988: BRS analysis of the non-Abelian chiral Schwinger model. Physical Review. D Particles and Fields 38(8): 2586-2590

Burnel; Van der Rest-Jaspers M 1988: BRS and anti-BRS symmetries in the planar gauge. Physical Review. D Particles and Fields 38(8): 2579-2585

Maharana 1988: BRST Hamiltonian quantization of a spinless particle in a curved background. Physical Review. D Particles and Fields 37(2): 555-557

González; Pullin 1990: BRST analysis of 2+1 gravity. Physical Review. D Particles and Fields 42(10): 3395-3400

Itoh; Kunitomo; Ohta; Sakaguchi 1993: BRST analysis of physical states in a two-dimensional black hole. Physical Review. D Particles and Fields 48(8): 3793-3808

Chang; Soo 1992: BRST cohomology and invariants of four-dimensional gravity in Ashtekar variables. Physical Review. D Particles and Fields 46(10): 4257-4262

Shin; Kim; Kim; Park 1992: BRST formulation of Chern-Simons gauge theory coupled to matter fields. Physical Review. D Particles and Fields 46(6): 2730-2733

Chung; Kim 1989: BRST invariance of the N-string vertex at space-time dimension fewer than 26. Physical Review. D Particles and Fields 40(10): 3537-3540

Tzani 1991: BRST light-cone quantization of the bosonic string Lagrangian. Physical Review. D Particles and Fields 43(4): 1254-1261

Bastianelli; Ohta 1994: BRST operator for the large N=4 superconformal algebra. Physical Review. D Particles and Fields 50(6): 4051-4059

Allen 1991: BRST quantization and coadjoint orbit theories. Physical Review. D Particles and Fields 43(10): 3442-3446

Fukai 1988: BRST quantization of a local supersymmetric chiral boson-fermion system. Physical Review. D Particles and Fields 37(12): 3582-3587

Braga 1995: BRST quantization of anomalous gauge theories. Physical Review. D Particles and Fields 51(10): 5905-5910

Voruganti 1989: BRST quantization of the CP1 model with Chern-Simons term in 2+1 dimensions. Physical Review. D Particles and Fields 39(4): 1179-1185

Braga; Montani 1994: BRST quantization of the chiral Schwinger model in the extended field-antifield space. Physical Review. D Particles and Fields 49(2): 1077-1080

Lin; Ni 1990: BRST quantization of the extended supersymmetric spinning particle. Physical Review. D Particles and Fields 41(4): 1307-1311

Das; Maharana; Roy 1989: BRST quantization of the superstring in background fields. Physical Review. D Particles and Fields 40(12): 4037-4046

Chen 1990: BRST quantization of topological field theory. Physical Review. D Particles and Fields 41(4): 1172-1176

Hwang; Lee 1993: BRST quantization of vector and axial-vector gauge theory. Physical Review. D Particles and Fields 48(10): 4916-4918

Ashtekar; Mazur; Torre 1987: BRST structure of general relativity in terms of new variables. Physical Review. D Particles and Fields 36(10): 2955-2962

Lee; Yee 1993: BRST symmetry in the Schrödinger picture. Physical Review. D Particles and Fields 47(10): 4608-4613

Cho; Chung; Jeong; Lee; Kim 1990: BRST- and OSP(1/2)-invariant N-superstring vertex at space-time dimension fewer than 10. Physical Review. D Particles and Fields 41(2): 704-707

García; Vergara; Urrutia 1995: BRST-BFV method for nonstationary systems. Physical Review. D Particles and Fields 51(10): 5806-5815

Okumura 1996: BRST-invariant Lagrangian of spontaneously broken gauge theories in a noncommutative geometry. Physical Review. D Particles and Fields 54(6): 4114-4120

Ohta 1988: BRST-invariant N-superstring vertices. Physical Review. D Particles and Fields 38(8): 2498-2506

Kobayashi; Konno; Suzuki 1991: BRST-invariant nonplanar primitive operators in the open-bosonic-string theory. Physical Review. D Particles and Fields 43(6): 1901-1913

Batlle; Gomis; Roca 1989: BRST-invariant path integral for a spinning relativistic particle. Physical Review. D Particles and Fields 40(6): 1950-1955

Kobayashi; Konno; Suzuki 1988: BRST-invariant tadpole calculation and diagrammatic formalism in the bosonic string. Physical Review. D Particles and Fields 38(4): 1150-1155

Shapiro; Thorn 1987: BRST-invariant transitions between closed and open strings. Physical Review. D Particles and Fields 36(2): 432-464

Gururangan, S.; McFarland, J.G.; Cines, D.B.; Skupski, D.; Bussel, J.B. 1998: BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology 20(3): 202-206

O'Brien, P. 1993: BS (British Standards) 5750: the message for managers. Health Manpower Management 19(4): 26-29

Manzanares, M.C.; Franch, J.; Carvalho, P.; Belmonte, A.M.; Tusell, J.; Franch, B.; Fernandez, J.M.; Clèries, L.; Morenza, J.L. 2001: BS-SEM evaluation of the tissular interactions between cortical bone and calcium-phosphate covered titanium implants. Bulletin du Groupement International Pour la Recherche Scientifique en Stomatologie and Odontologie 43(3): 100-108

Lightfoot, G. 1999: BSA recommended procedure. British Journal of Audiology 33(5): 349-350

Williams, I.D. 1993: BSAC guidelines on sensitivity testing. Journal of Antimicrobial ChemoTherapy 31(6): 1001-1004

Davids, E.; Ogilvie, A. 1995: Differences in distribution and synthesis of the functional opponents alpha 1-proteinase inhibitor and neutrophil elastase in eukaryotic cells. Histochemistry and Cell Biology 104(3): 245-253

Kovac, C.R.; Emelyanov, A.; Singh, M.; Ashouian, N.; Birshtein, B.K. 2000: BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence. Journal of Biological Chemistry 275(22): 16752-16757

Wildgoose, W. 2002: Editing a BSAVA manual: a practitioner's perspective. Journal of Small Animal Practice 43(6): 281-282

Marcos, M.; Giménez, R.; Serrano, J.L.; Donnio, B.; Heinrich, B.; Guillon, D. 2001: Dendromesogens: liquid crystal organizations of poly(amidoamine) dendrimers versus starburst structures. Chemistry 7(5): 1006-1013

Scott-Park, F. 2002: BSAVA's position on electronic training devices for dogs and cats. British Small Animal Veterinary Association. Journal of Small Animal Practice 43(12): 567

Chen, W.; Wang, J.; Ma, Y.; Wang, Y.; Yang, J. 2016: Advances in Researches on the Relations between miRNA-143/miRNA-145 and Colorectal Cancer. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 33(6): 1220-1224

Dudding, N.; Sutton, J. 2002: BSCC terminology conference, koilocytosis and mild dyskaryosis. Cytopathology: official journal of the British Society for Clinical Cytology 13(6): 379-381

Enders, M.; Fröhlich, E.; Hassler, D.; Kretzschmar, H. 2001: BSE (bovine spongiform encephalopathy) and the new variant of Creutzfeldt-Jakob disease. Deutsche Medizinische Wochenschrift 126(4): A55-A56

Poser, S. 2002: BSE - a cause for Creutzfeldt- Jakob disease?. Deutsche Medizinische Wochenschrift 127(7): 311

Baylis, M.; Houston, F.; Kao, R.R.; McLean, A.R.; Hunter, N.; Gravenor, M.B. 2002: BSE - a wolf in sheep's clothing?. Trends in Microbiology 10(12): 563-570

Ehmann, J.L. 1993: BSE Rap: intergenerational ties to save lives. Oncology Nursing Forum 20(8): 1255-1259

Delamothe, T. 1996: BSE agent: there may be even more trouble ahead. Bmj 313(7051): 189-190

Collins, J.D. 1997: BSE and British cattle exports. Veterinary Record 141(11): 286; Author Reply 287

Whitworth, C.L. 2001: BSE and dentistry. British Dental Journal 190(8): 407

Laubenthal, H. 1997: BSE and heparin and gelatin preparations. Der Anaesthesist 46(3): 253-254

Fraser, H. 1998: BSE and hindsight. Veterinary Record 142(9): 227

Bol, P. 2001: BSE and other prion diseases. Nederlands Tijdschrift Voor Tandheelkunde 108(2): 72-73

Overgaauw, P.A. 2001: BSE and pet food: is animal feed safe?. Tijdschrift Voor Diergeneeskunde 126(8): 292

Done, J. 1996: BSE and rabies policies: science or sophistry?. Veterinary Record 139(6): 148

Groschup, M.H.; Stolze, A. 2002: BSE and scrapie diagnosis in Germany. Berliner und Munchener Tierarztliche Wochenschrift 115(3-4): 106-110

Van 't Hooft, A.J.G. 2002: BSE and species specificity. Tijdschrift Voor Diergeneeskunde 127(5): 175

Brown, P. 2000: BSE and transmission through blood. Lancet 356(9234): 955-956

Salzberger, B.; Diehl, V.; Kurth, R. 2002: BSE and vCJD. new infectious prion diseases. Der Internist 43(6): 707-708

Jaumann, M.P. 2002: BSE and vCJD. Relevance for the established ENT physician. Hno 50(4): 364-368

Beale, A.J. 2001: BSE and vCJD: what is the future?. Journal of the Royal Society of Medicine 94(5): 207-209

Ferguson-Smith, M.A. 2001: BSE and variant CJD. Assumption that BSE originated from scrapie in sheep led to misjudgment. Bmj 322(7301): 1544-1545

Grant, H. 2001: BSE and variant CJD. Humans can live with BSE so long as they do not eat brains. Bmj 322(7301): 1545

Tacke, V. 2001: BSE as an organizational construction: a case study on the globalization of risk. British Journal of Sociology 52(2): 293-312

Keith, N.W. 1995: BSE compensation. Veterinary Record 137(18): 472

Fricker, J. 2001: BSE crisis--transmission through blood transfusions?. Trends in Molecular Medicine 7(1): 2-3

Meyer, H.P.; Rothuizen, J.; van Sluijs, F.J.; Voorhout, G.; van den Brom, W.E. 1999: Progressive remission of portosystemic shunting in 23 dogs after partial closure of congenital portosystemic shunts. Veterinary Record 144(13): 333-337

McGregor, A. 1996: BSE fears stir the Swiss. Lancet 347(9007): 1035

Simmons, M.M.; Harris, P.; Jeffrey, M.; Meek, S.C.; Blamire, I.W.; Wells, G.A. 1996: BSE in Great Britain: consistency of the neurohistopathological findings in two random annual samples of clinically suspect cases. Veterinary Record 138(8): 175-177

Donnelly, C.A.; Santos, R.; Ramos, M.; Galo, A.; Simas, J.P. 1999: BSE in Portugal: anticipating the decline of an epidemic. Journal of Epidemiology and Biostatistics 4(4): 277-283

Fleetwood, A. 2002: BSE in cattle born after July 31, 1996, in Great Britain. Veterinary Record 151(18): 551; Author Reply 552

De Mol, R.M. 2001: Automated detection of estrus and mastitis in dairy cows. Tijdschrift Voor Diergeneeskunde 126(4): 99-103

Balter, M. 2002: BSE in sheep? Humiliated lab fights to save face. Science 295(5556): 792-793

Abbasi, K. 2000: BSE inquiry plays down errors. Bmj 321(7269): 1097

Ashraf, H. 2000: BSE inquiry uncovers "a peculiarly British disaster". Lancet 356(9241): 1579-1580

Dillner, L. 1996: BSE linked to new variant of CJD in humans. Bmj 312(7034): 795

Podger, G. 2001: BSE report. Lancet 357(9253): 397-398

Faull, W.B.; Hughes, J.W.; Clarkson, M.J.; Downham, D.Y.; Manson, F.J.; Merritt, J.B.; Murray, R.D.; Russell, W.B.; Sutherst, J.E.; Ward, W.R. 1996: Epidemiology of lameness in dairy cattle: the influence of cubicles and indoor and outdoor walking surfaces. Veterinary Record 139(6): 130-136

Marwick, C. 1997: BSE sets agenda for imported gelatin. JAMA 277(21): 1659-1660

Urlings, B.; Bianchi, A. 2001: BSE testing in the Netherlands. Tijdschrift Voor Diergeneeskunde 126(2): 46-49

Urlings, B. 2001: BSE tests are negative in 17,000 cows. Tijdschrift Voor Diergeneeskunde 126(3): 72

Williams, N. 2001: BSE uncertainties drag on. Current Biology: Cb 11(22): R895

Zenner, H.-P. 2002: BSE virus in the tonsils?. Hno 50(4): 281

Riemer, C.; Simon, D.; Neidhold, S.; Schultz, J.; Schwarz, A.; Baier, M. 2002: BSE, scrapie, and vCJD: infectious neurodegenerative diseases. Ernst Schering Research Foundation Workshop 39: 85-103

Danner, K. 1993: BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry. Developments in Biological Standardization 80: 199-205

Paukstadt, W. 2001: BSE-cattle in Germany. Must we soon also count on vCJK patients?. MMW Fortschritte der Medizin 143(4): 12-13

Matthews, B. 2001: BSE/TSE risks associated with active pharmaceutical ingredients and starting materials: the situation in Europe and the global implications for healthcare manufacturers. PDA Journal of Pharmaceutical Science and Technology 55(5): 295-328

Zenilman, J.M. 1997: New paradigms for sexually transmitted diseases surveillance and field studies. Sexually Transmitted Diseases 24(5): 310-311

Plum, J. 1997: BSE: can we predict the future?. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 59(5): 435-449

Van Wuijckhuise, L.; Vellema, P.; Terbijhe, R.J. 2001: BSE: clinical diagnosis and field experience. Tijdschrift Voor Diergeneeskunde 126(8): 279-281

Hay, J.; Seal, D.V. 1996: BSE: cow politics revisited. Journal of the Royal Society of Medicine 89(11): 659-660

Brown, P. 1998: BSE: the final resting place. Lancet 351(9110): 1146-1147

Andreas, M.; Debong, B. 1996: BSG accepts point value decline in ambulatory surgery for 1993 and 1994. Decisions of the Federal Social Court 7 February 1996--6 RKa 61/94 and 42/95. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 67(10): Suppl. 243-5

Blasingame, D. 1988: BSi plan protects hospital employee, patients. Texas Hospitals 43(11): 38

Adler-Michaelson, P. 1996: BSL/ACLS--historical development (basic life support/ advanced cardiac life support). Therapeutische Umschau. Revue Therapeutique 53(8): 609-610

Wilkerson, J.B. 1997: BSN education. Imprint 44(5): 39-41

Anonymous 1984: BSN offered at hospital nursing school through consortium agreement. Hospital progress 65(1): 21

Mattera, M.D. 2000: BSN on your terms!. Rn 63(5): 7

Hinzmann, C. 1996: BSN students present research findings on complex health problems in poster session format. Journal of Nursing Education 35(4): 177-178

Buryska, J. 1999: A pastoral voice in the healthcare wilderness. Health Progress 80(2): 96; 95

Christiansen, D. 1998: BSN-seeker objects to repeating nursing courses. American Nurse 30(1): 4

Petrusyte, M.; Rudokas, K.; Maneliene, Z.; Kiuduliene, E.; Butkus, V.; Janulaitis, A. 1993: BSP1407I, a restriction endonuclease from Bacillus stearothermophilus, which recognizes novel palindromic sequence 5'-T decreases GTACA-3'. Nucleic Acids Research 21(10): 2514

Henry, K. 1996: BSS: tracking trends in sexual behavior. Aidscaptions 3(2): 33

Jukes, T.H. 1994: BST and milk production. Science 265(5169): 170

Dean, S.P. 1994: BST ban. Veterinary Record 134(10): 255

Gloyd, J.S. 1993: BST product labels--still FDA's call. Journal of the American Veterinary Medical Association 202(12): 1923

Mignogna, G.; Pascarella, S.; Wechselberger, C.; Hinterleitner, C.; Mollay, C.; Amiconi, G.; Barra, D.; Kreil, G. 1996: BSTI, a trypsin inhibitor from skin secretions of Bombina bombina related to protease inhibitors of nematodes. Protein Science: a Publication of the Protein Society 5(2): 357-362

Donkin, F. 1985: BScN by 2000: one nurse's perspective. Hospital Trustee 9(1): 23-24

Koizumi, M.; Kimura, K.; Toyota, T. 1995: BT-PABA test. Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 1088-1091

Fischer, S.; Kraft, W. 1993: BT-PABA/xylose test in the cat?. Tierarztliche Praxis 21(2): 159-162

Fontaniere, B.; Ranchere, D.; Michot, J.P.; Barfety-Michot, B.; Genna, L.; Charles, N.; Marechal, J.M.; Colombel, M. 2000: BTA test (Bard test) and urinary cytology. Annales de Pathologie 20 Suppl: S88-S91

Heino, A.; Aaltomaa, S.; Ala-Opas, M. 1999: BTA test is superior to voided urine cytology in detecting malignant bladder tumours. Annales Chirurgiae et Gynaecologiae 88(4): 304-307

Yoshida, C.; Igarashi, K. 1999: BTB/POZ domain proteins in nuclear structure and DNA loop formation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 44(12 Suppl): 1771-1779

Martin-Fardon, R.ém.; Weiss, F. 2002: BTCP is a potent reinforcer in rats: comparison of behavior maintained on fixed- and progressive-ratio schedules. Pharmacology Biochemistry and Behavior 72(1-2): 343-353

Watanabe, N.; Kurabayashi, M.; Shimomura, Y.; Kawai-Kowase, K.; Hoshino, Y.; Manabe, I.; Watanabe, M.; Aikawa, M.; Kuro-o, M.; Suzuki, T.; Yazaki, Y.; Nagai, R. 1999: BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circulation Research 85(2): 182-191

Wojtowicz-Praga, S. 1999: Clinical potential of matrix metalloprotease inhibitors. Drugs in R&d 1(2): 117-129

Islam, T.C.; Brandén, L.J.; Kohn, D.B.; Islam, K.B.; Smith, C.I. 2000: BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones. Journal of Gene Medicine 2(3): 204-209

Tao, L.; Boyd, M.; Gonye, G.; Malone, B.; Schwaber, J. 2000: BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations. Human Mutation 16(6): 528-529

Vihinen, M.; Iwata, T.; Kinnon, C.; Kwan, S.P.; Ochs, H.D.; Vorechovský, I.; Smith, C.I. 1996: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Research 24(1): 160-165

Dickinson, K.; North, T.J.; Sills, S.; Anthony, D.M.; Lock, J.I.; Vowles, D.T.; Jones, R.B. 1997: BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets. European Journal of Pharmacology 339(1): 69-76

Kaye, P.; O'Sullivan, I. 2001: BTS asthma guide. Thorax 56(8): 666

Holford, J.; Raynaud, F.; Murrer, B.A.; Grimaldi, K.; Hartley, J.A.; Abrams, M.; Kelland, L.R. 1998: Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473). Anti-Cancer Drug Design 13(1): 1-18

Gould, I.M. 2002: BTS guidelines on CAP. Community acquired pneumonia. Thorax 57(7): 657

Anonymous 1998: BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 53 Suppl. 1: S1-S8

Reich, J.M. 1997: BTS sarcoidosis study. Thorax 52(1): 102

Fielder, R.J.; Atterwill, C.K.; Anderson, D.; Boobis, A.R.; Botham, P.; Chamberlain, M.; Combes, R.; Duffy, P.A.; Lewis, R.W.; Lumley, C.E.; Kimber, I.; Newall, D.R. 1997: BTS working party report on in vitro toxicology. Human and Experimental Toxicology 16 Suppl. 1: S1-40

Pfeffer, H.U.; Breuer, L. 2000: BTX measurements with diffusive samplers in the vicinity of a cokery: comparison between ORSA-type samplers and pumped sampling. Journal of Environmental Monitoring: Jem 2(5): 483-486

Zhu, K.; Xu, Y.; Zhong, J.; Chen, S.; Zeng, H. 2002: BU-CTX(2) as conditioning regimen for allogeneic hematopoietic stem cell transplantation in sixty patients with leukemia. Zhonghua Xue Ye Xue Za Zhi 23(7): 349-352

Ortman, R.A.; Holderbaum, D.; Qu, X.M.; Banerjee, S.; Haqqi, T.M. 1994: BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type Ii collagen-induced arthritis. Journal of Immunology 152(8): 4175-4182

Torres, G. 1995: BUCAST: another new antiviral. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 9(11): 4-5

Okada, K.; Oguchi, N.; Shinohara, K.; Tamura, N.; Ishii, K.; Noguchi, Y.; Hayashi, S.; Yamamoto, H.; Takeichi, M.; Fujimoto, H.; Shirota, T.; Hayashi, T. 1997: BUN, Bence Jones protein, and chromosomal aberrations predict survival in multiple myeloma. Japanese Journal of Clinical Hematology 38(12): 1254-1262

Howell, F. 1998: BUPA and the tobacco industry. Chairperson of BUPA in Republic of Ireland is also chairperson of tobacco producer. Bmj 316(7134): 864

Ferriman 1999: BUPA moves towards managed care. Bmj 319(7201): 9b

Goodman, R.E. 1996: BUPA's discretionary recognition of treatment. Psychosexual medicine is no longer recognised for benefit purposes. Bmj 312(7028): 447

Crompton, S. 1988: BUPA: doing the NHS a favour?. Health Service Journal 98(5100): 531

Heid, O. 1997: BURST excitation pulses. Magnetic Resonance in Medicine 38(4): 585-590

Yung, W.K. 1999: BUdR radiosensitization in anaplastic astrocytoma. International Journal of Radiation Oncology Biology Physics 45(5): 1105-1106

Alexander, L.L. 1999: BV public policy: issues and challenges. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 67 Suppl. 1: S13-S15

Floore, T.G.; Dukes, J.C.; Cuda, J.P.; Schreiber, E.T.; Greer, M.J. 1998: BVA 2 mosquito larvicide--a new surface oil larvicide for mosquito control. Journal of the American Mosquito Control Association 14(2): 196-199

Beswick, W.; Blackburn, T.; Brancker, M.; Chandler, T.; Crooks, J.; Gunn, D.; Haxby, D.; Hellig, H.; Hoskin, B.; Linklater, K.; Parry, J.; Steele-Bodger, A.; Stockman, M.; Tandy, J.; Tavemor, D.; Taylor, A. 2002: BVA governance. British Veterinary Association. Veterinary Record 151(8): 247; Author Reply 247

Brunner, C.; Kreth, H.W.; Ochs, H.D.; Schuster, V. 2002: Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia. Journal of Clinical Immunology 22(4): 244-251

Anonymous 1993: BVA/Kennel Club/International Sheepdog Society Eye Scheme: notes on procedure. Veterinary Record 132(6): 137-141

Rutstein, R.P.; Corliss, D.A. 2000: BVAT distance vs. near stereopsis screening of strabismus, strabismic amblyopia and refractive amblyopia; a prospective study of 68 patients. Binocular Vision and Strabismus Quarterly 15(3): 229-236

Lutz, S. 1988: BVC trying to acquire Gateway in stock swap. Modern Healthcare 18(2): 6-7

Verberne, L.R. 2000: BVD approach: vaccination and eradication. Tijdschrift Voor Diergeneeskunde 125(7): 218-221

Verberne, L.R. 2000: BVD control: about persistent shedders and "quiet" carriers. Tijdschrift Voor Diergeneeskunde 125(21): 659-660

Stelwagen, J.; Dijkhuizen, A.A. 1998: BVD outbreak can be costly: a case report. Tijdschrift Voor Diergeneeskunde 123(9): 283-286

Nettleton, P.F.; Gunn, G. 2002: BVD virus genotype 2 in British cattle. Veterinary Record 151(20): 616

Depner, K.; Hübschle, O.J.; Liess, B. 1991: BVD-virus infection in goats-experimental studies on transplacental transmissibility of the virus and its effect on reproduction. Archives of Virology. Supplementum 3: 253-256

Thorp, B.; McMullin, P.F. 1998: BVPA guidelines on antimicrobial resistance. Veterinary Record 143(7): 203

Swanson, R.A.; Sharp, F.R. 1994: BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 25(1): 225-226

Legrand, V.; Vrolix, M.; De Bruyne, B.; Wijns, W.; Heyndrickx, G.; De Scheerder, I.; Taeymans, Y.; Vrints, C.; Materne, P.; Benit, E.; Col, J.; Boland, J.; De Keyser, J.M.; Lafontaine, P.; Renkin, J. 1997: BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive Cardiology. Acta Cardiologica 52(6): 507-514

Elices, M.J. 2002: BX-471 Berlex. Current Opinion in Investigational Drugs 3(6): 865-869

Solleder, P.; Beller, K.D.; Linder, R. 1996: BY963: a sonographic contrast medium. Academic Radiology 3(Suppl 2): S194-S197

Xu, L. 2002: BYY harmony learning, structural RPCL, and topological self-organizing on mixture models. Neural Networks: the Official Journal of the International Neural Network Society 15(8-9): 1125-1151

Gstaiger, M.; Hovens, C.; Georgiev, O.; Knoepfel, L.; Schaffner, W. 1996: BZLF1 (ZEBRA, Zta) protein of Epstein-Barr virus selected in a yeast one-hybrid system by binding to a consensus site in the IgH intronic enhancer: a role in immunoglobulin expression?. Biological Chemistry 377(10): 669-673

Van Agen, B.; Maas, L.M.; Zwingmann, I.H.; Van Schooten, F.J.; Kleinjans, J.C. 1997: B[a]P-DNA adduct formation and induction of human epithelial lung cell transformation. Environmental and Molecular Mutagenesis 30(3): 287-292

Liu; Olson; Yang; Gu; Lynch; Arko; List; Bartlett; Veal; Liu; Paulikas; Vandervoort 1989: Ba 4d core-level spectroscopy in the YBa2Cu3O6.9 high-Tc superconductor: Existence of a surface-shifted component. Physical Review. B Condensed Matter 40(4): 2650-2653

Jones; Dai; Gallagher 1990: Ba 6pjnfj' autoionizing series. Physical Review. a Atomic Molecular and Optical Physics 41(1): 316-326

Jaffe; Kachru; van Linden van den Heuvell HB; Gallagher 1985: Ba 6png, J=3 and J=5 autoionizing states. Physical Review. a General Physics 32(3): 1480-1488

Yang; Schrott; Tsuei 1990: Ba core-level shift in x-ray photoemission spectroscopy on single-phase Y1-xPrxBa2Cu3O7 and YBa2Cu3O7-y compounds. Physical Review. B Condensed Matter 41(13): 8921-8926

Jahreiss; Huber 1985: Ba oscillator strengths from a laser-excited vapor. Physical Review. A General Physics 31(2): 692-699

Yamane, H.; Sasaki, S.; Kubota, S.; Kajiwara, T.; Shimada, M. 2002: Ba(14)Cu(2)In(4)N(7), a new subnitride with isolated nitridocuprate groups and indium clusters. Acta Crystallographica. Section C Crystal Structure Communications 58(Part 4): I50-I52

Mestdagh; Meynadier; de Pujo P; Sublemontier; Visticot; Berlande; Cuvellier; Gustavsson; Suits; Lee 1993: Ba(6s6p P11,mj)-->Ba(6s6p P32,mj') Zeeman cross sections in single collisions with N2, O2, and H2. Physical Review. A Atomic Molecular and Optical Physics 47(1): 241-254

Turicnik, A.; Benkic, P.; Zemva, B. 2002: Ba(SbF(6))(2).5XeF(2): first xenon(II) compound with barium. Synthesis, vibrational spectra, and crystal structure. Inorganic Chemistry 41(21): 5521-5524

McMahon; Degtyareva; Nelmes 2000: Ba-IV-type incommensurate crystal structure in group-V metals. Physical Review Letters 85(23): 4896-4899

Licheron; Gervais 1993: Ba2-xKxPb1-yBiyO4- delta : Layered oxides with insulating or conducting properties and possible superconducting properties. Physical Review. B Condensed Matter 47(13): 8008-8015

Cava; Batlogg; Fleming; Sunshine; Ramirez; Rietman; Zahurak; van Dover RB 1988: Ba2-xLaxYCu3O7+/- delta perovskite compounds: Crystal chemistry. Physical Review. B Condensed Matter 37(10): 5912-5915

Thomas; Orenstein; Rapkine; Capizzi; Millis; Bhatt; Schneemeyer; Waszczak 1988: Ba2YCu3O7- delta : Electrodynamics of crystals with high reflectivity. Physical Review Letters 61(11): 1313-1316

Wengert, S.; Willems, J.B.; Nesper, R. 2001: Ba4Si3Br2: a double salt of barium bromide and barium silicide containing a novel cyclotrisilicide unit. Chemistry 7(15): 3209-3213

Jeon; Liang; Chen; Croft; Ruckman; Di Marzio D; Hegde 1990: BaBiO3 and the effect of potassium substitution using photoemission. Physical Review. B Condensed Matter 41(7): 4066-4071

Vandamme, A.M. 1996: BaEV is a relic from an ancient retrovirus that crossed species barriers. Trends in Microbiology 4(12): 478

O'Connor, B.B.; Rockney, R.; Alario, A. 2002: BaFá BaFá: a cross-cultural simulation experience for medical educators and trainees. Medical Education 36(11): 1102

Litt, H.I.; Brody, A.S. 2001: BaSO4-loaded agarose: a construction material for multimodality imaging phantoms. Academic Radiology 8(5): 377-383

Haig, A.J.; Harris, A.; Quint, D.J. 2001: Baastrup's disease correlating with diffuse lumbar paraspinal atrophy: a case report. Archives of Physical Medicine and Rehabilitation 82(2): 250-252

Babbitt, B. 1985: Babbitt believes Arizona's AHCCCS program can serve as nation's indigent care model. Review - Federation of American Hospitals 18(5): 36-37

Brenner, C.; Levin, K. 1998: Babbling of an infant with a repaired cleft lip: a case study. South African Journal of Communication Disorders 45: 31-37

Voisin, A.; Elliott, D.B.; Regan, D.; Ruth, G.H. 1997: Babe Ruth: with vision like that, how could he hit the ball?. Optometry and Vision Science: Official Publication of the American Academy of Optometry 74(3): 144-146

Morgan, F. 1997: Babe the magnificent organ donor? the perils and promises surrounding xenotransplantation. Journal of Contemporary Health Law and Policy 14(1): 127-160

Dwyer, J. 2001: Babel, justice, and democracy: reflections on a shortage of interpreters at a public hospital. Hastings Center Report 31(2): 31-36

Giamarchi; Shastry 1992: Baber scattering and resistivity of a two-dimensional two-band model. Physical Review. B Condensed Matter 46(9): 5528-5535

Wehrhahn; Appel 1986: Baber scattering in strong magnetic fields: the effect of Landau quantization. Physical Review. B Condensed Matter 34(2): 748-755

Wen-Hua, L.; Peng, W. 2016: Advances in research of stem cell therapy for human parasitic diseases: a review. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 28(6): 740-744

Rugel, J. 2000: Babes in arms. Juvenile access to guns in Minnesota. Minnesota Medicine 83(9): 18-22

Pallarito, K. 1996: Babes in managed care land. Provider-sponsored networks are stepping cautiously into risk contracting. Modern Healthcare 26(47): 34-6 38 40

Katz, K.; Naré, C. 2002: Reproductive health knowledge and use of services among young adults in Dakar, Senegal. Journal of Biosocial Science 34(2): 215-231

Steel, R.J. 1999: Babesia and Ehrlichia seropositive horses temporarily imported into Australia. Australian Veterinary Journal 77(11): 726; Discussion 727

Goff, W.L.; Johnson, W.C.; Cluff, C.W. 1998: Babesia bovis immunity. in vitro and in vivo evidence for IL-10 regulation of IFN-gamma and iNOS. Annals of the new York Academy of Sciences 849: 161-180

Marsaudon, E.; Camenen, J.; Testou, D.; Bourrée, P.; Samson, P.; Luneau, F. 1995: Babesia canis human babesiosis causing a 40-day anuria. Annales de Medecine Interne 146(6): 451-452

Arai, S.; Tsuji, M.; Kim, S.J.; Nakade, T.; Kanno, Y.; Ishihara, C. 1998: Babesia canis infection in canine-red blood cell-substituted SCID mice. International Journal for Parasitology 28(9): 1429-1435

L'Hostis, M.; Chauvin, A. 1999: Babesia divergens in France: descriptive and analytical epidemiology. Parassitologia 41(Suppl 1): 59-62

Irizarry-Rovira, A.R..; Stephens, J.; Christian, J.; Kjemtrup, A.; DeNicola, D.B..; Widmer, W.R..; Conrad, P.A.. 2001: Babesia gibsoni infection in a dog from indiana. Veterinary Clinical Pathology 30(4): 180-188

Burkot, T.R.; Schneider, B.S.; Pieniazek, N.J.; Happ, C.M.; Rutherford, J.S.; Slemenda, S.B.; Hoffmeister, E.; Maupin, G.O.; Zeidner, N.S. 2000: Babesia microti and Borrelia bissettii transmission by Ixodes spinipalpis ticks among prairie voles, Microtus ochrogaster, in Colorado. Parasitology 121 Pt 6: 595-599

Shen, Y.; Gao, J.; Xu, K.; Xue, L.; Zhang, Y.; Shi, B.; Li, D.; Wei, X.; Higuchi, S. 1997: Babesiasis in Nanjing area, China. Tropical Animal Health and Production 29(4 Suppl): 19s-22s

Smith, R.D.; Evans, D.E.; Martins, J.R.; Ceresér, V.H.; Correa, B.L.; Petraccia, C.; Cardozo, H.; Solari, M.A.; Nari, A. 2000: Babesiosis (Babesia bovis) stability in unstable environments. Annals of the new York Academy of Sciences 916: 510-520

Yin, H.; Lu, W.; Luo, J. 1997: Babesiosis in China. Tropical Animal Health and Production 29(4 Suppl): 11S-15S

Enemark, H.; Petersen, J.E. 1998: Babesiosis in Denmark. Ugeskrift for Laeger 160(43): 6225

Quick, R.E.; Herwaldt, B.L.; Thomford, J.W.; Garnett, M.E.; Eberhard, M.L.; Wilson, M.; Spach, D.H.; Dickerson, J.W.; Telford, S.R.; Steingart, K.R.; Pollock, R.; Persing, D.H.; Kobayashi, J.M.; Juranek, D.D.; Conrad, P.A. 1993: Babesiosis in Washington State: a new species of Babesia?. Annals of Internal Medicine 119(4): 284-290

López Jiménez, L. 1997: Babesiosis in a splenectomized patient. Is it the first case in Spain?. Medicina Clinica 108(18): 717

Weiss, L.M. 2002: Babesiosis in humans: a treatment review. Expert Opinion on PharmacoTherapy 3(8): 1109-1115

Wiercińska-Drapało, A.; Grzeszczuk, A.; Panasiuk, A.; Prokopowicz, D. 1998: Babesiosis-disease of humans and animals. Polskie Archiwum Medycyny Wewnetrznej 99(3): 239-244

Persing, D.H.; Conrad, P.A. 1995: Babesiosis: new insights from phylogenetic analysis. Infectious Agents and Disease 4(4): 182-195